1
|
Naser-Tavakolian A, Gale R, Luu M, Masterson JM, Venkataramana A, Khodyakov D, Anger JT, Posadas E, Sandler H, Freedland SJ, Spiegel B, Daskivich TJ. Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations. Med Decis Making 2024; 44:320-334. [PMID: 38347686 DOI: 10.1177/0272989x241228612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2024]
Abstract
BACKGROUND Physician treatment preference may influence how risks are communicated in prostate cancer consultations. We identified persuasive language used when describing cancer prognosis, life expectancy, and side effects in relation to a physician's recommendation for aggressive (surgery/radiation) or nonaggressive (active surveillance/watchful waiting) treatment. METHODS A qualitative analysis was performed on transcribed treatment consultations of 40 men with low- and intermediate-risk prostate cancer across 10 multidisciplinary providers. Quotes pertaining to cancer prognosis, life expectancy, and side effects were randomized. Coders predicted physician treatment recommendations from isolated blinded quotes. Testing characteristics of consensus predictions against the physician's treatment recommendation were reported. Coders then identified persuasive strategies favoring aggressive/nonaggressive treatment for each quote. Frequencies of persuasive strategies favoring aggressive/nonaggressive treatment were reported. Logistic regression quantified associations between persuasive strategies and physician treatment recommendations. RESULTS A total of 496 quotes about cancer prognosis (n = 127), life expectancy (n = 51), and side effects (n = 318) were identified. The accuracy of predicting treatment recommendation based on individual quotes containing persuasive language (n = 256/496, 52%) was 91%. When favoring aggressive treatment, persuasive language downplayed side effect risks and amplified cancer risk (recurrence, progression, or mortality). Significant predictors (P < 0.05) of aggressive treatment recommendation included favorable side effect interpretation, downplaying side effects, and long time horizon for cancer risk due to longevity. When favoring nonaggressive treatment, persuasive language amplified side effect risks and downplayed cancer risk. Significant predictors of nonaggressive treatment recommendation included unfavorable side effect interpretation, favorable interpretation of cancer risk, and short time horizon for cancer risk due to longevity. CONCLUSIONS Physicians use persuasive language favoring their preferred treatment, regardless of whether their recommendation is appropriate. IMPLICATIONS Clinicians should quantify risk so patients can judge potential harm without solely relying on persuasive language. HIGHLIGHTS Physicians use persuasive language favoring their treatment recommendation when communicating risks of prostate cancer treatment, which may influence a patient's treatment choice.Coders predicted physician treatment recommendations based on isolated, randomized quotes about cancer prognosis, life expectancy, and side effects with 91% accuracy.Qualitative analysis revealed that when favoring nonaggressive treatment, physicians used persuasive language that amplified side effect risks and downplayed cancer risk. When favoring aggressive treatment, physicians did the opposite.Providers should be cognizant of using persuasive strategies and aim to provide quantified assessments of risk that are jointly interpreted with the patient so that patients can make evidence-based conclusions regarding risks without solely relying on persuasive language.
Collapse
Affiliation(s)
| | - Rebecca Gale
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Michael Luu
- Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - John M Masterson
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | | | | | - Jennifer T Anger
- Department of Urology, University of California, San Diego, San Diego, CA, USA
| | - Edwin Posadas
- Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Howard Sandler
- Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Stephen J Freedland
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Section of Urology, Durham VA Medical Center, Durham, NC, USA
| | - Brennan Spiegel
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Department of Medicine, Divisions of Gastroenterology and Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Timothy J Daskivich
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA
| |
Collapse
|
2
|
Daskivich TJ, Naser-Tavakolian A, Gale R, Luu M, Friedrich N, Venkataramana A, Khodyakov D, Posadas E, Sandler H, Spiegel B, Freedland SJ. Variation in communication of side effects in prostate cancer treatment consultations. Prostate Cancer Prostatic Dis 2024:10.1038/s41391-024-00806-2. [PMID: 38396054 DOI: 10.1038/s41391-024-00806-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2023] [Revised: 01/29/2024] [Accepted: 02/06/2024] [Indexed: 02/25/2024]
Abstract
BACKGROUND Effective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate cancer. We sought to qualitatively characterize how physicians communicate SE in consultations. METHODS We transcribed 50 initial prostate cancer treatment consultations across nine multidisciplinary providers (Urologists, Radiation Oncologists, Medical Oncologists) at our tertiary referral, academic center. Coders identified quotes describing SE and used an inductive approach to establish a hierarchy for granularity of communication: (1) not mentioned, (2) name only, (3) generalization("high"), (4) average incidence without timepoint, (5) average incidence with timepoint, and (6) precision estimate. We reported the most granular mode of communication for each SE throughout the consultation overall and across specialty and tumor risk. RESULTS Among consultations discussing surgery (n = 40), erectile dysfunction (ED) and urinary incontinence (UI) were omitted in 15% and 12%, not quantified (name only or generalization) in 47% and 30%, and noted as average incidence without timeline in 8% and 8%, respectively. In only 30% and 49% were ED and UI quantified with timeline (average incidence with timeline or precision estimate), respectively. Among consultations discussing radiation (n = 36), irritative urinary symptoms, ED, and other post-radiotherapy SE were omitted in 22%, 42%, and 64-67%, not quantified in 61%, 33%, and 23-28%, and noted as average incidence without timeline in 8%, 22%, and 6-8%, respectively. In only 3-8% were post-radiotherapy SE quantified with timeline. Specialty concordance (but not tumor risk) was associated with higher granularity of communication, though physicians frequently failed to quantify specialty-concordant SE. CONCLUSIONS SE was often omitted, not quantified, and/or lacked a timeline in treatment consultations in our sample. Physicians should articulate, quantify, and assign a timeline for SE to optimize SDM.
Collapse
Affiliation(s)
- Timothy J Daskivich
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA.
| | | | - Rebecca Gale
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Michael Luu
- Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Nadine Friedrich
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Abhi Venkataramana
- Institute of Urology, University of Southern California, Los Angeles, CA, USA
| | | | - Edwin Posadas
- Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Howard Sandler
- Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Brennan Spiegel
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Department of Medicine, Divisions of Gastroenterology and Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Stephen J Freedland
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Section of Urology, Durham VA Medical Center, Durham, NC, USA
| |
Collapse
|
3
|
Bodnar LM, Johansson K, Himes KP, Khodyakov D, Abrams B, Parisi SM, Hutcheon JA. Do current pregnancy weight gain guidelines balance risks of adverse maternal and child health in a United States cohort? Am J Clin Nutr 2024; 119:527-536. [PMID: 38182445 PMCID: PMC10884606 DOI: 10.1016/j.ajcnut.2023.10.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 09/01/2023] [Accepted: 10/11/2023] [Indexed: 01/07/2024] Open
Abstract
BACKGROUND The Institute of Medicine pregnancy weight gain guidelines were developed without evidence linking high weight gain to maternal cardiometabolic disease and child obesity. The upper limit of current recommendations may be too high for the health of the pregnant individual and child. OBJECTIVES The aim of this study was to identify the range of pregnancy weight gain for pregnancies within a normal body mass index (BMI) range that balances the risks of high and low weight gain by simultaneously considering 10 different health conditions. METHODS We used data from an United States prospective cohort study of nulliparae followed until 2 to 7 y postpartum (N = 2344 participants with a normal BMI). Pregnancy weight gain z-score was the main exposure. The outcome was a composite consisting of the occurrence of ≥1 of 10 adverse health conditions that were weighted for their seriousness. We used multivariable Poisson regression to relate weight gain z-scores with the weighted composite outcome. RESULTS The lowest risk of the composite outcome was at a pregnancy weight gain z-score of -0.6 SD (standard deviation) (equivalent to 13.1 kg at 40 wk). The weight gain ranges associated with no more than 5%, 10%, and 20% increase in risks were -1.0 to -0.2 SD (11.2-15.3 kg), -1.4 to 0 SD (9.4-16.4 kg), and -2.0 to 0.4 SD (7.0-18.9 kg). When we used a lower threshold to define postpartum weight increase in the composite outcome (>5 kg compared with >10 kg), the ranges were 1.6 to -0.7 SD (8.9-12.6 kg), -2.2 to -0.3 SD (6.3-14.7 kg), and ≤0.2 SD (≤17.6 kg). Compared with the ranges of the current weight gain guidelines (-0.9 to -0.1 SD, 11.5-16 kg), the lower limits from our data tended to be lower while upper limits were similar or lower. CONCLUSIONS If replicated, our results suggest that policy makers should revisit the recommended pregnancy weight gain range for individuals within a normal BMI range.
Collapse
Affiliation(s)
- Lisa M Bodnar
- Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Magee-Womens Research Institute, Pittsburgh, PA, United States.
| | - Kari Johansson
- Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden
| | - Katherine P Himes
- Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Magee-Womens Research Institute, Pittsburgh, PA, United States
| | | | - Barbara Abrams
- Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA, United States
| | - Sara M Parisi
- Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
| | - Jennifer A Hutcheon
- Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, Canada
| |
Collapse
|
4
|
Jones KF, Khodyakov D, Han BH, Arnold RM, Dao E, Morrison J, Kapo J, Meier DE, Paice JA, Liebschutz JM, Ritchie CS, Merlin JS, Bulls HW. Expert consensus-based guidance on approaches to opioid management in individuals with advanced cancer-related pain and nonmedical stimulant use. Cancer 2023; 129:3978-3986. [PMID: 37691479 PMCID: PMC10910244 DOI: 10.1002/cncr.34921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Revised: 03/19/2023] [Accepted: 04/17/2023] [Indexed: 09/12/2023]
Abstract
BACKGROUND Clinicians treating cancer-related pain with opioids regularly encounter nonmedical stimulant use (i.e., methamphetamine, cocaine), yet there is little evidence-based management guidance. The aim of the study is to identify expert consensus on opioid management strategies for an individual with advanced cancer and cancer-related pain with nonmedical stimulant use according to prognosis. METHODS The authors conducted two modified Delphi panels with palliative care and addiction experts. In Panel A, the patient's prognosis was weeks to months and in Panel B the prognosis was months to years. Experts reviewed, rated, and commented on the case using a 9-point Likert scale from 1 (very inappropriate) to 9 (very appropriate) and explained their responses. The authors applied the three-step analytical approach outlined in the RAND/UCLA to determine consensus and level of clinical appropriateness of management strategies. To better conceptualize the quantitative results, they thematically analyzed and coded participant comments. RESULTS Consensus was achieved for all management strategies. The 120 Experts were mostly women (47 [62%]), White (94 [78%]), and physicians (115 [96%]). For a patient with cancer-related and nonmedical stimulant use, regardless of prognosis, it was deemed appropriate to continue opioids, increase monitoring, and avoid opioid tapering. Buprenorphine/naloxone transition was inappropriate for a patient with a short prognosis and of uncertain appropriateness for a patient with a longer prognosis. CONCLUSION Study findings provide urgently needed consensus-based guidance for clinicians managing cancer-related pain in the context of stimulant use and highlight a critical need to develop management strategies to address stimulant use disorder in people with cancer. PLAIN LANGUAGE SUMMARY Among palliative care and addiction experts, regardless of prognosis, it was deemed appropriate to continue opioids, increase monitoring, and avoid opioid tapering in the context of cancer-related pain and nonmedical stimulant use. Buprenorphine/naloxone transition as a harm reduction measure was inappropriate for a patient with a short prognosis and of uncertain appropriateness for a patient with a longer prognosis.
Collapse
Affiliation(s)
- Katie Fitzgerald Jones
- New England Geriatric Research, Education and Clinical Center and Division of Palliative Care, VA Boston Healthcare System, Boston, Massachusetts, USA
| | | | - Benjamin H. Han
- Division of Geriatrics, Gerontology, and Palliative Care, University of California, San Diego, California, USA
| | - Robert M. Arnold
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Emily Dao
- RAND Corporation, Santa Monica, California, USA
| | - Jeni Morrison
- Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Jennifer Kapo
- Palliative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
| | - Diane E. Meier
- Department of Geriatrics and Palliative Medicine, Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Judith A. Paice
- Division Hematology-Oncology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
| | - Jane M. Liebschutz
- Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Christine S. Ritchie
- Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Jessica S. Merlin
- Challenges in Managing and Preventing Pain Clinical Research Center, Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Hailey W. Bulls
- Challenges in Managing and Preventing Pain Clinical Research Center, Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| |
Collapse
|
5
|
Khodyakov D, Grant S, Kroger J, Gadwah-Meaden C, Motala A, Larkin J. Disciplinary trends in the use of the Delphi method: A bibliometric analysis. PLoS One 2023; 18:e0289009. [PMID: 37582076 PMCID: PMC10427003 DOI: 10.1371/journal.pone.0289009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Accepted: 07/10/2023] [Indexed: 08/17/2023] Open
Abstract
The Delphi method is an iterative, anonymous, group-based process for eliciting and aggregating opinion on a topic to explore the existence of consensus among experts. The year 2023 marks the 60th anniversary of the first peer-reviewed journal article on the Delphi method. Originally developed for operations research, this method is now applied extensively by researchers representing diverse scientific fields. We used a bibliometric analysis to describe general trends in the expansion of its use across disciplines over time. We conducted a systematic literature search for all English-language, peer-reviewed journal articles on the Delphi method through its first 60 years. We found 19,831 articles: 96.8% (n = 19,204) on the actual use of the Delphi method in an empirical study and 3.2% (n = 627) describing, examining, or providing some guidance on how to use the Delphi method. Almost half (49.9%) of all articles were published in the 2010s and an additional third (32.5%) in the first few years of the 2020s. Nearly two-thirds (65%, n = 12,883) of all published articles have appeared in medical journals, compared to 15% in science and technology (n = 3,053) or social science (n = 3,016) journals. We conclude that the expanded use of the Delphi method has been driven largely by the medical field, though social scientists and technologists continue to be at the forefront of methodological work on the Delphi method. Therefore, we call for greater transdisciplinary collaboration on methodological guidance and standards for the Delphi method.
Collapse
Affiliation(s)
- Dmitry Khodyakov
- RAND Corporation, Santa Monica, California, United States of America
| | - Sean Grant
- RAND Corporation, Santa Monica, California, United States of America
- HEDCO Institute for Evidence-Based Educational Practice, College of Education, University of Oregon, Eugene, Oregon, United States of America
| | - Jack Kroger
- RAND Corporation, Santa Monica, California, United States of America
- Pardee RAND Graduate School, Santa Monica, California, United States of America
| | - Catria Gadwah-Meaden
- RAND Corporation, Santa Monica, California, United States of America
- Pardee RAND Graduate School, Santa Monica, California, United States of America
| | - Aneesa Motala
- RAND Corporation, Santa Monica, California, United States of America
| | - Jody Larkin
- RAND Corporation, Pittsburgh, Pennsylvania, United States of America
| |
Collapse
|
6
|
Daskivich TJ, Gale R, Luu M, Naser-Tavakolian A, Venkataramana A, Khodyakov D, Anger JT, Posadas E, Sandler H, Spiegel B, Freedland SJ. Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment Consultations. J Urol 2022; 208:301-308. [PMID: 35377775 PMCID: PMC11070128 DOI: 10.1097/ju.0000000000002675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/17/2022] [Indexed: 11/26/2022]
Abstract
PURPOSE Men with prostate cancer prefer patient-specific, quantitative assessments of longevity in shared decision making. We sought to characterize how physicians communicate the 3 components of competing risks-life expectancy (LE), cancer prognosis and treatment-related survival benefit-in treatment consultations. MATERIALS AND METHODS Conversation related to LE, cancer prognosis and treatment-related survival benefit was identified in transcripts from treatment consultations of 42 men with low- and intermediate-risk disease across 10 multidisciplinary providers. Consensus of qualitative coding by multiple reviewers noted the most detailed mode of communication used to describe each throughout the consultation. RESULTS Physicians frequently failed to provide patient-specific, quantitative estimates of LE and cancer mortality. LE was omitted in 17% of consultations, expressed as a generalization (eg "long"/"short") in 17%, rough number of years in 31%, probability of mortality/survival at an arbitrary timepoint in 17% and in only 19% as a specific number of years. Cancer mortality was omitted in 24% of consultations, expressed as a generalization in 7%, years of expected life in 2%, probability at no/arbitrary timepoint in 40% and in only 26% as the probability at LE. Treatment-related survival benefit was often omitted; cancer mortality was reported without treatment in 38%, with treatment in 10% and in only 29% both with and without treatment. Physicians achieved "trifecta"-1) quantifying probability of cancer mortality 2) with and without treatment 3) at the patient's LE-in only 14% of consultations. CONCLUSIONS Physicians often fail to adequately quantify competing risks. We recommend the "trifecta" approach, reporting 1) probability of cancer mortality 2) with and without treatment 3) at the patient's LE.
Collapse
Affiliation(s)
- Timothy J. Daskivich
- Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA
| | - Rebecca Gale
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA
| | - Michael Luu
- Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, CA
| | | | - Abhi Venkataramana
- Department of Urology, University of Southern California, Los Angeles, CA
| | | | - Jennifer T. Anger
- Department of Urology, University of California, San Diego, San Diego, CA
| | - Edwin Posadas
- Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA
| | - Howard Sandler
- Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA
| | - Brennan Spiegel
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA
- Department of Medicine, Divisions of Gastroenterology and Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA
| | - Stephen J. Freedland
- Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA
- Section of Urology, Durham VA Medical Center, Durham, NC
| |
Collapse
|
7
|
Fitzgerald Jones K, Khodyakov D, Arnold R, Bulls H, Dao E, Kapo J, Meier D, Paice J, Liebschutz J, Ritchie C, Merlin J. Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder. JAMA Oncol 2022; 8:1107-1114. [PMID: 35771550 DOI: 10.1001/jamaoncol.2022.2191] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Importance Opioid misuse and opioid use disorder (OUD) are important comorbidities in people with advanced cancer and cancer-related pain, but there is a lack of consensus on treatment. Objective To develop consensus among palliative care and addiction specialists on the appropriateness of various opioid management strategies in individuals with advanced cancer-related pain and opioid misuse or OUD. Design, Setting, and Participants For this qualitative study, using ExpertLens, an online platform and methodology for conducting modified Delphi panels, between August and October 2020, we conducted 2 modified Delphi panels to understand the perspectives of palliative and addiction clinicians on 3 common clinical scenarios varying by prognosis (weeks to months vs months to years). Of the 129 invited palliative or addiction medicine specialists, 120 participated in at least 1 round. A total of 84 participated in all 3 rounds. Main Outcomes and Measures Consensus was investigated for 3 clinical scenarios: (1) a patient with a history of an untreated opioid use disorder, (2) a patient taking more opioid than prescribed, and (3) a patient using nonprescribed benzodiazepines. Results Participants were mostly women (47 [62%]), White (94 (78 [65%]), and held MD/DO degrees (115 [96%]). For a patient with untreated OUD, regardless of prognosis, it was deemed appropriate to begin treatment with buprenorphine/naloxone and inappropriate to refer to a methadone clinic. Beginning split-dose methadone was deemed appropriate for patients with shorter prognoses and of uncertain appropriateness for those with longer prognoses. Beginning a full opioid agonist was deemed of uncertain appropriateness for those with a short prognosis and inappropriate for those with a longer prognosis. Regardless of prognosis, for a patient with no medical history of OUD taking more opioids than prescribed, it was deemed appropriate to increase monitoring, inappropriate to taper opioids, and of uncertain appropriateness to increase the patient's opioids or transition to buprenorphine/naloxone. For a patient with a urine drug test positive for non-prescribed benzodiazepines, regardless of prognosis, it was deemed appropriate to increase monitoring, inappropriate to taper opioids and prescribe buprenorphine/naloxone. Conclusions and Relevance The findings of this qualitative study provide urgently needed consensus-based guidance for clinicians and highlight critical research and policy gaps.
Collapse
Affiliation(s)
- Katie Fitzgerald Jones
- William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts.,VA Boston Healthcare System, Boston, Massachusetts
| | | | - Robert Arnold
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Hailey Bulls
- CHAllenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Emily Dao
- RAND Corporation, Santa Monica, California
| | - Jennifer Kapo
- MSCE Palliative Medicine, Yale University School of Medicine, New Haven, Connecticut
| | - Diane Meier
- Department of Geriatrics and Palliative Medicine, Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Judith Paice
- RN Feinberg School of Medicine, Division of Hematology-Oncology, Northwestern University, Chicago, Illinois
| | - Jane Liebschutz
- Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Christine Ritchie
- Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston
| | - Jessica Merlin
- CHAllenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
| |
Collapse
|
8
|
Abstract
OBJECTIVE The authors sought to identify the most promising strategies for improving the mental health guardianship process in Los Angeles County for adults with mental illness who are gravely disabled. METHODS In May and June 2019, 56 experts, working in hospitals or outpatient facilities or representing legal, advocacy, policy, or forensic organizations, participated in an online modified-Delphi panel, rating the ethical appropriateness, impact on care quality, efficiency, and feasibility of nine strategies for improvement of mental health guardianship. Agreement was determined with the RAND/UCLA appropriateness method, and comments were thematically analyzed. RESULTS The strategy ranked highest by the participating experts was improving the administrative functioning and judicial processes of entities involved in mental health guardianship proceedings-it was the only strategy that achieved agreement among panelists and was rated highly on all four criteria. Other preferred strategies were enhancing the ability of assertive outpatient mental health teams to serve individuals before they experience a crisis and expanding the continuum of unlocked residential treatment settings. CONCLUSIONS Opportunities exist to improve all stages of the mental health guardianship process. Experts favored strategies that streamline administrative processes, facilitate community integration into treatment, and ensure fidelity to best practices. Improving the mental health guardianship process has the potential to speed up delivery of services, better manage resources, and increase access to treatment for individuals with mental illness who are gravely disabled.
Collapse
Affiliation(s)
- Amy L Shearer
- Behavioral and Policy Sciences, RAND Corporation, Santa Monica, California (Shearer, Khodyakov);DMH+UCLA Public Mental Health Partnership, University of California, Los Angeles (Bromley);Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Bromley);Los Angeles County Department of Mental Health, Los Angeles (Bonds, Draxler);California Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science, Willowbrook (Bonds)
| | - Elizabeth Bromley
- Behavioral and Policy Sciences, RAND Corporation, Santa Monica, California (Shearer, Khodyakov);DMH+UCLA Public Mental Health Partnership, University of California, Los Angeles (Bromley);Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Bromley);Los Angeles County Department of Mental Health, Los Angeles (Bonds, Draxler);California Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science, Willowbrook (Bonds)
| | - Curley Bonds
- Behavioral and Policy Sciences, RAND Corporation, Santa Monica, California (Shearer, Khodyakov);DMH+UCLA Public Mental Health Partnership, University of California, Los Angeles (Bromley);Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Bromley);Los Angeles County Department of Mental Health, Los Angeles (Bonds, Draxler);California Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science, Willowbrook (Bonds)
| | - Connie Draxler
- Behavioral and Policy Sciences, RAND Corporation, Santa Monica, California (Shearer, Khodyakov);DMH+UCLA Public Mental Health Partnership, University of California, Los Angeles (Bromley);Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Bromley);Los Angeles County Department of Mental Health, Los Angeles (Bonds, Draxler);California Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science, Willowbrook (Bonds)
| | - Dmitry Khodyakov
- Behavioral and Policy Sciences, RAND Corporation, Santa Monica, California (Shearer, Khodyakov);DMH+UCLA Public Mental Health Partnership, University of California, Los Angeles (Bromley);Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Bromley);Los Angeles County Department of Mental Health, Los Angeles (Bonds, Draxler);California Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science, Willowbrook (Bonds)
| |
Collapse
|
9
|
Naser-Tavakolian A, Gale R, Luu M, Venkataramana A, Khodyakov D, Posadas E, Sandler H, Anger J, Spiegel B, Freedland S, Daskivich T. MP31-14 VARIATION IN COMMUNICATION OF SIDE EFFECTS IN PROSTATE CANCER TREATMENT CONSULTATIONS. J Urol 2022. [DOI: 10.1097/ju.0000000000002580.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Eibner C, Buttorff C, Cefalu M, Khodyakov D, Taylor EA. The Effect of the Medicare Advantage Value-Based Insurance Design Model Test on Utilization in 2017. Am J Health Promot 2022; 36:740-745. [PMID: 35420449 DOI: 10.1177/08901171211073408a] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In 2015, the Centers for Medicare and Medicaid Services announced the Medicare Advantage (MA) Value-Based Insurance Design (VBID) model test, which allows MA insurers to use flexible benefit design strategies, such as reduced cost-sharing, to encourage beneficiaries with chronic disease to use high-value care. During the first year of implementation (2017), nine MA insurers offered VBID in 45 health plans to a total of 96 053 eligible beneficiaries. We used MA encounter data to estimate the impact of VBID on health services utilization in 2017 using a difference-in-differences research design. We found that VBID increased use of 10 out of 18 targeted services, and led to general increases in primary care visits, specialty care visits, and drug fills across eligible beneficiaries. The model was also associated with increases in ambulatory care sensitive inpatient and emergency department visits, an unanticipated effect that may be temporary. Overall, our findings suggest that VBID successfully increased the use of high-value services among eligible MA beneficiaries, an important first step along the pathway to better chronic disease management, lower spending, and improved beneficiary health.
Collapse
|
11
|
Jilani SM, Jones HE, Grossman M, Jansson LM, Terplan M, Faherty LJ, Khodyakov D, Patrick SW, Davis JM. Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate. J Pediatr 2022; 243:33-39.e1. [PMID: 34942181 DOI: 10.1016/j.jpeds.2021.12.021] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Revised: 11/22/2021] [Accepted: 12/05/2021] [Indexed: 12/31/2022]
Abstract
OBJECTIVE To standardize the clinical definition of opioid withdrawal in neonates to address challenges in clinical care, quality improvement, research, and public policy for this patient population. STUDY DESIGN Between October and December 2020, we conducted 2 modified-Delphi panels using ExpertLens, a virtual platform for performing iterative expert engagement panels. Twenty clinical experts specializing in care for the substance-exposed mother-neonate dyad explored the necessity of key evidence-based clinical elements in defining opioid withdrawal in the neonate leading to a diagnosis of neonatal abstinence syndrome (NAS)/neonatal opioid withdrawal syndrome (NOWS). Expert consensus was assessed using descriptive statistics, the RAND/UCLA Appropriateness Method, and thematic analysis of participants' comments. RESULTS Expert panels concluded the following were required for diagnosis: in utero exposure (known by history, not necessarily by toxicology testing) to opioids with or without the presence of other psychotropic substances, and the presence of at least two of the most common clinical signs characteristic of withdrawal (excessive crying, fragmented sleep, tremors, increased muscle tone, gastrointestinal dysfunction). CONCLUSIONS Results indicate that both a known history of in utero opioid exposure and a distinct set of withdrawal signs are necessary to standardize a definition of neonatal withdrawal. Implementation of a standardized definition requires both patient engagement and a mother-neonate dyadic approach mindful of program and policy implications.
Collapse
Affiliation(s)
- Shahla M Jilani
- Office of the Assistant Secretary for Health, US Department of Health and Human Services, Washington, DC
| | - Hendrée E Jones
- Department of Obstetrics and Gynecology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
| | - Matthew Grossman
- Department of Pediatrics, Yale School of Medicine, New Haven, CT
| | - Lauren M Jansson
- Department of Pediatrics, Center for Addiction and Pregnancy, Johns Hopkins University School of Medicine, Baltimore, MD
| | | | - Laura J Faherty
- Pardee RAND Graduate School, Santa Monica, CA; Department of Pediatrics, Boston University School of Medicine, Boston, MA
| | | | - Stephen W Patrick
- Division of Neonatology, Department of Pediatrics and Department of Health Policy, Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, TN
| | - Jonathan M Davis
- Division of Newborn Medicine, Tufts Children's Hospital and the Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA
| |
Collapse
|
12
|
Aguilar-Gaxiola S, Ahmed SM, Anise A, Azzahir A, Baker KE, Cupito A, Eder M, Everette TD, Erwin K, Felzien M, Freeman E, Gibbs D, Greene-Moton E, Hernández-Cancio S, Hwang A, Jones F, Jones G, Jones M, Khodyakov D, Michener JL, Milstein B, Oto-Kent DS, Orban M, Pusch B, Shah M, Shaw M, Tarrant J, Wallerstein N, Westfall JM, Williams A, Zaldivar R. Assessing Meaningful Community Engagement: A Conceptual Model to Advance Health Equity through Transformed Systems for Health: Organizing Committee for Assessing Meaningful Community Engagement in Health & Health Care Programs & Policies. NAM Perspect 2022; 2022:202202c. [PMID: 35891775 PMCID: PMC9303007 DOI: 10.31478/202202c] [Citation(s) in RCA: 35] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/20/2023]
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Elmer Freeman
- Center for Community Health Education Research and Service
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Radomski TR, Decker A, Khodyakov D, Thorpe CT, Hanlon JT, Roberts MS, Fine MJ, Gellad WF. Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults. JAMA Netw Open 2022; 5:e2148599. [PMID: 35166780 PMCID: PMC8848205 DOI: 10.1001/jamanetworkopen.2021.48599] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
IMPORTANCE Metrics that detect low-value care in common forms of health care data, such as administrative claims or electronic health records, primarily focus on tests and procedures but not on medications, representing a major gap in the ability to systematically measure low-value prescribing. OBJECTIVE To develop a scalable and broadly applicable metric that contains a set of quality indicators (EVOLV-Rx) for use in health care data to detect and reduce low-value prescribing among older adults and that is informed by diverse stakeholders' perspectives. DESIGN, SETTING, AND PARTICIPANTS This qualitative study used an online modified-Delphi method to convene an expert panel of 15 physicians and pharmacists. This panel, comprising clinicians, health system leaders, and researchers, was tasked with rating and discussing candidate low-value prescribing practices that were derived from medication safety criteria; peer-reviewed literature; and qualitative studies of patient, caregiver, and physician perspectives. The RAND ExpertLens online platform was used to conduct the activities of the panel. The panelists were engaged for 3 rounds between January 1 and March 31, 2021. MAIN OUTCOMES AND MEASURES Panelists used a 9-point Likert scale to rate and then discuss the scientific validity and clinical usefulness of the criteria to detect low-value prescribing practices. Candidate low-value prescribing practices were rated as follows: 1 to 3, indicating low validity or usefulness; 3.5 to 6, uncertain validity or usefulness; and 6.5 to 9, high validity or usefulness. Agreement among panelists and the degree of scientific validity and clinical usefulness were assessed using the RAND/UCLA (University of California, Los Angeles) Appropriateness Method. RESULTS Of the 527 low-value prescribing recommendations identified, 27 discrete candidate low-value prescribing practices were considered for inclusion in EVOLV-Rx. After round 1, 18 candidate practices were rated by the panel as having high scientific validity and clinical usefulness (scores of ≥6.5). After round 2 panel deliberations, the criteria to detect 19 candidate practices were revised. After round 3, 18 candidate practices met the inclusion criteria, receiving final median scores of 6.5 or higher for both scientific validity and clinical usefulness. Of those practices that were not included in the final version of EVOLV-Rx, 3 received high scientific validity (scores ≥6.5) but uncertain clinical usefulness (scores <6.5) ratings, whereas 6 received uncertain scientific validity rating (scores <6.5). CONCLUSIONS AND RELEVANCE This study culminated in the development of EVOLV-Rx and involved a panel of experts who identified the 18 most salient low-value prescribing practices in the care of older adults. Applying EVOLV-Rx may enhance the detection of low-value prescribing practices, reduce polypharmacy, and enable older adults to receive high-value care across the full spectrum of health services.
Collapse
Affiliation(s)
- Thomas R. Radomski
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
- Center for Health Equity Research and Promotion (CHERP), Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
| | - Alison Decker
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Center for Health Equity Research and Promotion (CHERP), Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
| | - Dmitry Khodyakov
- RAND Corporation, Pardee RAND Graduate School, Santa Monica, California
| | - Carolyn T. Thorpe
- Center for Health Equity Research and Promotion (CHERP), Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
- Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill
| | - Joseph T. Hanlon
- Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
- Center for Health Equity Research and Promotion (CHERP), Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
- Division of Geriatric Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Geriatric Research Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
| | - Mark S. Roberts
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania
| | - Michael J. Fine
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Center for Health Equity Research and Promotion (CHERP), Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
| | - Walid F. Gellad
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
- Center for Health Equity Research and Promotion (CHERP), Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
| |
Collapse
|
14
|
Khodyakov D, Park S, Hutcheon JA, Parisi SM, Bodnar LM. The impact of panel composition and topic on stakeholder perspectives: Generating hypotheses from online maternal and child health modified-Delphi panels. Health Expect 2022; 25:732-743. [PMID: 34989087 PMCID: PMC8957726 DOI: 10.1111/hex.13420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 11/08/2021] [Accepted: 12/14/2021] [Indexed: 11/29/2022] Open
Abstract
Introduction Multistakeholder engagement is crucial for conducting health services research. Delphi‐based methodologies combining iterative rounds of questions with feedback on and discussion of group results are a well‐documented approach to multistakeholder engagement. This study develops hypotheses about the impact of panel composition and topic on the propensity and meaningfulness of response changes in multistakeholder modified‐Delphi panels. Methods We conducted three online modified‐Delphi (OMD) multistakeholder panels using the same protocol. We assigned 60 maternal and child health professionals to a homogeneous (professionals only) panel, 60 pregnant or postpartum women (patients) to a homogeneous panel, and 30 professionals and 30 patients to a mixed panel. In Round 1, participants rated the seriousness of 11 maternal and child health outcomes using a 0–100 scale and explained their ratings. In Round 2, participants saw their own and their panel's Round 1 results and discussed them using asynchronous, anonymous discussion boards moderated by the study investigators. In Round 3, participants revised their original ratings. Our outcome measures included binary indicators of response changes to ratings of the low, medium and high severity maternal and child health outcomes and their meaningfulness, measured by a change of 10 or more points. Results Participants changed 818 of 1491 (55%) of responses; the majority of response changes were meaningful. Patterns of response changes were different for patients and professionals and for different levels of outcome seriousness. Using study results and the literature, we developed three hypotheses. First, OMD participants, regardless of their stakeholder group, are more likely to change their responses on preference‐sensitive topics where there is a range of viable alternatives or perspectives. Second, patients are more likely to change their responses and to do so meaningfully in mixed panels, whereas professionals are more likely to do so in homogeneous panels. Third, the association between panel composition and response change varies according to the topic (e.g., the level of outcome seriousness). Conclusions Results of our work not only helped generate empirically derived hypotheses to be tested in future research but also offer practical recommendations for designing multistakeholder OMD panels. Patient or Public Contribution Pregnant or postpartum women were involved in this study.
Collapse
Affiliation(s)
- Dmitry Khodyakov
- RAND Health Care, RAND Corporation, Pardee RAND Graduate School, Santa Monica, California, USA
| | - Sujeong Park
- School of Public Affairs, The Pennsylvania State University - Harrisburg, Middletown, Pennsylvania, USA
| | - Jennifer A Hutcheon
- Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada
| | - Sara M Parisi
- Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
| | - Lisa M Bodnar
- Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
| |
Collapse
|
15
|
Merlin JS, Khodyakov D, Arnold R, Bulls HW, Dao E, Kapo J, King C, Meier D, Paice J, Ritchie C, Liebschutz JM. Expert Panel Consensus on Management of Advanced Cancer-Related Pain in Individuals With Opioid Use Disorder. JAMA Netw Open 2021; 4:e2139968. [PMID: 34962565 DOI: 10.1001/jamanetworkopen.2021.39968] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
IMPORTANCE Opioid use disorder (OUD) is an important comorbidity in individuals with advanced cancer, in whom pain is common. Full-agonist opioid medications are the cornerstone of cancer pain management, but the existing literature does not address how to manage cancer pain in patients with OUD. OBJECTIVE To conduct an expert panel to develop consensus on the appropriateness of management of cancer pain in individuals with co-occurring advanced cancer and OUD. EVIDENCE REVIEW A 3-round modified Delphi process was completed from August to October 2020 with 2 cases: patient with advanced cancer, pain, and OUD treated with buprenorphine-naloxone or methadone. Participants rated management strategies in round 1, discussed results in round 2, and provided final responses in round 3. ExpertLens, an online approach to conducting modified Delphi panels, was used. Participants were experts in palliative care, addiction, or both, recruited by email from palliative care and addiction-focused professional groups, lists from prior studies, and snowball sampling. Data analysis was performed from November 2020 to July 2021. FINDINGS Of 120 experts (median age, 40-49 years), most were White (78 participants [94%]), female (74 participants [62%]), and held MD or DO degrees (115 participants [96%]); 84 (70%) participated in all rounds. For a patient with OUD taking buprenorphine-naloxone, it was deemed appropriate to continue buprenorphine-naloxone with thrice-daily dosing. Continuing buprenorphine-naloxone and adding a full-agonist opioid was deemed to be appropriate for patients with a prognosis of weeks to months and of uncertain appropriateness for patients with a prognosis of months to years. For a patient with OUD taking methadone dispensed at a methadone clinic, it was deemed appropriate to take over prescribing and dose twice or thrice daily. Continuing methadone daily while adding another full-agonist opioid was deemed appropriate for patients with a prognosis of weeks to months and of uncertain appropriateness for those with a prognosis of months to years. CONCLUSIONS AND RELEVANCE The findings of this qualitative study provide urgently needed, consensus-based guidance for clinicians and highlight critical research and policy gaps needed to facilitate implementation.
Collapse
Affiliation(s)
- Jessica S Merlin
- CHAllenges in Managing and Preventing Pain Clinical Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania
- Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania
| | | | - Robert Arnold
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Hailey W Bulls
- CHAllenges in Managing and Preventing Pain Clinical Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania
- Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Emily Dao
- RAND Corporation, Santa Monica, California
| | - Jennifer Kapo
- Palliative Medicine, Yale University School of Medicine, New Haven, Connecticut
| | - Caroline King
- Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland
| | - Diane Meier
- Department of Geriatrics and Palliative Medicine, Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Judith Paice
- Feinberg School of Medicine, Division Hematology-Oncology, Northwestern University, Chicago, Illinois
| | - Christine Ritchie
- Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston
| | - Jane M Liebschutz
- Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania
| |
Collapse
|
16
|
Daskivich TJ, Gale R, Luu M, Khodyakov D, Anger JT, Freedland SJ, Spiegel B. Patient Preferences for Communication of Life Expectancy in Prostate Cancer Treatment Consultations. JAMA Surg 2021; 157:70-72. [PMID: 34757389 DOI: 10.1001/jamasurg.2021.5803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Affiliation(s)
- Timothy J Daskivich
- Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California.,Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, California
| | - Rebecca Gale
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, California
| | - Michael Luu
- Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, California
| | | | - Jennifer T Anger
- Department of Urology, University of California, San Diego, San Diego
| | - Stephen J Freedland
- Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California
| | - Brennan Spiegel
- Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, California.,Division of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California
| |
Collapse
|
17
|
Khodyakov D, Buttorff C, Xenakis L, Damberg CL, Ridgely MS. Alignment Between Objective and Subjective Assessments of Health System Performance: Findings From a Mixed-Methods Study. J Healthc Manag 2021; 66:380-394. [PMID: 34495002 DOI: 10.1097/jhm-d-20-00249] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
EXECUTIVE SUMMARY The article examines whether subjective performance assessments from health system executives match objective performance assessments and qualitatively explores ways to achieve high performance. We interviewed 138 C-suite executives of 24 health systems in California, Minnesota, Washington, and Wisconsin between 2017 and 2019. We used maximum variation sampling to select health systems to achieve diversity in performance on objective measures of clinical performance. Our interviews focused on executives' perceptions of their own health system's performance and factors they thought generally contributed to high performance. In our analysis, we grouped health systems based on objective performance levels (high, medium, and low) used in sampling, compared objective performance ratings with executives' subjective performance assessments, and used thematic analysis to identify reasons for subjective assessment of health system performance and levers of high performance in general. There was poor agreement between objective and subjective performance assessments (kappa = 0.082). Subjective assessments were higher than objective assessments and captured more factors than are typically considered in performance accountability and value-based payment initiatives. Executives whose views were inconsistent with objective performance assessments did not cite clinical care quality per se as the basis for their assessment, focusing instead on market competition, financial performance, and high customer satisfaction and loyalty. Executives who cited clinical quality metrics as the basis of their assessment offered subjective ratings consistent with objective ratings. Executives identified organizational culture, organizational governance, and staff engagement as levers for achieving high performance. Future research should explore the benefits and drawbacks of considering subjective performance assessments in value-based payment initiatives.
Collapse
|
18
|
Khodyakov D, Jilani SM, Dellva S, Faherty LJ. Informing the Development of a Standardized Clinical Definition of Neonatal Abstinence Syndrome: Protocol for a Modified-Delphi Expert Panel. JMIR Res Protoc 2021; 10:e25387. [PMID: 34491203 PMCID: PMC8456327 DOI: 10.2196/25387] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 07/09/2021] [Accepted: 07/10/2021] [Indexed: 11/18/2022] Open
Abstract
Background Neonatal abstinence syndrome (NAS) is a postnatal withdrawal syndrome that most commonly results from prenatal opioid exposure. Every 15 minutes, an infant is born in the United States with signs of NAS. The field lacks a standardized clinical definition of NAS, complicating discussions on programmatic and policy development to support opioid-exposed mothers and infants. Objective The goal of this paper is to describe a protocol for a systematic expert panel process to inform the development of a clinical definition of NAS. Methods We will conduct two three-round online modified-Delphi panels using the ExpertLens system and will follow the recommendations for Conducting and REporting of DElphi Studies (CREDES). One panel will focus on developing key components of a clinical definition of NAS, and the second panel will focus on neonatal opioid withdrawal syndrome (NOWS), which is a term that has come into use to differentiate opioid-exposed infants from infants exposed to other substances in utero. However, there is lack of agreement on the precise clinical definition of NOWS and how it is distinct from or overlaps with NAS. Each panel will complete two rating rounds and a discussion round using a similar protocol. We will analyze all rating data descriptively and determine the presence of agreement within and between the two panels. We will also perform thematic analysis of the qualitative comments to contextualize the panel findings. Results The panels were convened between October 29 and December 17, 2020. Their results were disseminated and discussed at a national conference on NAS that took place on March 17-18, 2021. Conclusions A standardized clinical definition of NAS will help to better characterize NAS incidence and to design effective clinical, public health, and policy interventions to support opioid-exposed mother-infant dyads. International Registered Report Identifier (IRRID) DERR1-10.2196/25387
Collapse
Affiliation(s)
- Dmitry Khodyakov
- RAND Corporation, Santa Monica, CA, United States.,Pardee RAND Graduate School, Santa Monica, CA, United States
| | - Shahla M Jilani
- Office of the Assistant Secretary for Health, US Department of Health & Human Services, Washington, DC, United States
| | | | - Laura J Faherty
- Pardee RAND Graduate School, Santa Monica, CA, United States.,RAND Corporation, Boston, MA, United States.,Boston University School of Medicine, Boston, MA, United States
| |
Collapse
|
19
|
Bodnar LM, Khodyakov D, Parisi SM, Himes KP, Burke JG, Hutcheon JA. Rating the seriousness of maternal and child health outcomes linked with pregnancy weight gain. Paediatr Perinat Epidemiol 2021; 35:459-468. [PMID: 33216402 PMCID: PMC8134513 DOI: 10.1111/ppe.12741] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 09/18/2020] [Accepted: 10/23/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND Current pregnancy weight gain guidelines were developed based on implicit assumptions of a small group of experts about the relative seriousness of adverse health outcomes. Therefore, they will not necessarily reflect the values of women. OBJECTIVE To estimate the seriousness of 11 maternal and child health outcomes that have been consistently associated with pregnancy weight gain by engaging patients and health professionals. METHODS We collected data using an online panel approach with a modified Delphi structure. We selected a purposeful sample of maternal and child health professionals (n = 84) and women who were pregnant or recently postpartum (patients) (n = 82) in the United States as panellists. We conducted three concurrent panels: professionals only, patients only, and patients and professionals. During a 3-round online modified Delphi process, participants rated the seriousness of health outcomes (Round 1), reviewed and discussed the initial results (Round 2), and revised their original ratings (Round 3). Panellists assigned seriousness ratings (0, [not serious] to 100 [most serious]) for infant death, stillbirth, preterm birth, gestational diabetes, preeclampsia, small-for-gestational-age (SGA) birth, large-for-gestational-age (LGA) birth, unplanned caesarean delivery, maternal obesity, childhood obesity, and maternal metabolic syndrome. RESULTS Each panel individually came to a consensus on all seriousness ratings. The final median seriousness ratings combined across all panels were highest for infant death (100), stillbirth (95), preterm birth (80), and preeclampsia (80). Obesity in children, metabolic syndrome in women, obesity in women, and gestational diabetes had median seriousness ratings ranging from 55 to 65. The lowest seriousness ratings were for SGA birth, LGA birth, and unplanned caesarean delivery (30-40). CONCLUSION Professionals and women rate some adverse outcomes as being more serious than others. These ratings can be used to establish the range of pregnancy weight gain associated with the lowest risk of a broad range of maternal and child health outcomes.
Collapse
Affiliation(s)
- Lisa M. Bodnar
- Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States,Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States
| | | | - Sara M. Parisi
- Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
| | - Katherine P. Himes
- Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States
| | - Jessica G. Burke
- Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA, United States
| | - Jennifer A. Hutcheon
- Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
20
|
Grant S, Armstrong C, Khodyakov D. Online Modified-Delphi: a Potential Method for Continuous Patient Engagement Across Stages of Clinical Practice Guideline Development. J Gen Intern Med 2021; 36:1746-1750. [PMID: 33742303 PMCID: PMC8175513 DOI: 10.1007/s11606-020-06514-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Accepted: 12/20/2020] [Indexed: 11/26/2022]
Affiliation(s)
- Sean Grant
- Department of Social & Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN USA
- RAND Health Care, RAND Corporation, Santa Monica, CA USA
| | | | | |
Collapse
|
21
|
King C, Arnold R, Dao E, Kapo J, Liebschutz J, Meier D, Paice J, Ritchie C, Czajkowski K, Khodyakov D, Merlin J. Consensus-based approach to managing opioids, including opioid misuse and opioid use disorder, in patients with serious illness: protocol for a modified Delphi process. BMJ Open 2021; 11:e045402. [PMID: 34011593 PMCID: PMC8137210 DOI: 10.1136/bmjopen-2020-045402] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
INTRODUCTION Management of opioid misuse and opioid use disorder (OUD) among individuals with serious illness is an important yet understudied issue. Palliative care clinicians caring for individuals with serious illness, many of whom may live for months or years, describe a complex tension between weighing the benefits of opioids, which are considered a cornerstone of pain management in serious illness, and serious opioid-related harms like opioid misuse and OUD. And yet, little literature exists to inform the management of opioid misuse and OUDs among individuals with serious illness. Our objective is to provide evidence-based management guidance to clinicians caring for individuals with serious illness who develop opioid misuse or OUD. METHODS AND ANALYSIS We chose a modified Delphi approach, which is appropriate when empirical evidence is lacking and expert input must be used to shape clinical guidance. We sought to recruit 60 clinicians with expertise in palliative care, addiction or both to participate in this study. We created seven patient cases that capture important management challenges in individuals with serious illness prescribed opioid therapy. We used ExpertLens, an online platform for conducting modified Delphi panels. Participants completed three rounds of data collection. In round 1, they rated and commented on the appropriateness of management choices for cases. In round 2, participants reviewed and discussed their own and other participants' round 1 numerical responses and comments. In round 3 (currently ongoing), participants again reviewed rounds 1 and 2, and are allowed to change their final numerical responses. We used ExpertLens to automatically identify whether there is consensus, or disagreement, among responses in panels. Only round 3 responses will be used to assess final consensus and disagreement. ETHICS AND DISSEMINATION This project received ethical approval from the University of Pittsburgh's Institutional Review Board (study 19110301) and the RAND Institutional Research Board (study 2020-0142). Guidance from this work will be disseminated through national stakeholder networks to gain buy-in and endorsement. This study will also form the basis of an implementation toolkit for clinicians caring for individuals with serious illness who are at risk of opioid misuse or OUD.
Collapse
Affiliation(s)
- Caroline King
- Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA
| | - Robert Arnold
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - Emily Dao
- Survey Research Group, RAND Corporation, Santa Monica, California, USA
| | - Jennifer Kapo
- Section of Geriatrics, Yale University School of Medicine, New Haven, Connecticut, USA
| | - Jane Liebschutz
- Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Diane Meier
- Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Judith Paice
- Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
| | - Christine Ritchie
- Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
| | - Kristen Czajkowski
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Dmitry Khodyakov
- Survey Research Group, RAND Corporation, Santa Monica, California, USA
| | - Jessica Merlin
- Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| |
Collapse
|
22
|
Lapane KL, Dubé C, Hume AL, Tjia J, Jesdale BM, Pawasauskas J, Khodyakov D. Priority-Setting to Address the Geriatric Pharmacoparadox for Pain Management: A Nursing Home Stakeholder Delphi Study. Drugs Aging 2021; 38:327-340. [PMID: 33624228 DOI: 10.1007/s40266-021-00836-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/16/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND Evidence to guide clinical decision making for pain management in nursing home residents is scant. OBJECTIVE Our objective was to explore the extent of consensus among expert stakeholders regarding what analgesic issues should be prioritized for comparative-effectiveness studies of beneficial and adverse effects of analgesic regimens in nursing home residents. METHODS Two stakeholder panels (nurses only and a mix of clinicians/researchers) were engaged (n = 83). During a three-round online modified Delphi process, participants rated and commented on the need for new evidence on nonopioid analgesic regimens and opioid regimens, short-term adverse effects, long-term adverse effects, comorbid conditions, and other factors in the nursing home setting (9-point scale; 1 = not essential to 9 = very essential to obtain new evidence). The quantitative data were analyzed to determine the existence of consensus using an approach from the RAND/UCLA Appropriateness Method User's Manual. The qualitative data, consisting of participant explanations of their numeric ratings, were thematically analyzed by an experienced qualitative researcher. RESULTS For nursing home residents, evidence generation was deemed essential for opioids, gabapentin (alone or with serotonin norepinephrine reuptake inhibitors [SNRIs]), and nonsteroid anti-inflammatory drugs with SNRIs. Experts prioritized the following outcomes as essential: long-term adverse effects, including delirium, cognitive decline, and decline in activities of daily living (ADLs). Kidney disease and depression were deemed essential conditions to consider in studies of pain medications. Coprescribing analgesic regimens with benzodiazepines, sedating medications, serotonergic medications, and non-SNRI antidepressants were considered essential areas of study. Experts noted that additional study was essential in residents with moderate/severe cognitive impairment and limitations in ADLs. CONCLUSIONS Stakeholder priorities for more evidence reflect concerns related to treating medically complex residents with complex drug regimens and included long-term adverse effects, coprescribing, and sedating medications. Carefully conducted observational studies are needed to address the vast evidence gap for nursing home residents.
Collapse
Affiliation(s)
- Kate L Lapane
- Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA.
| | - Catherine Dubé
- Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA
| | - Anne L Hume
- Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA
| | - Jennifer Tjia
- Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA
| | - Bill M Jesdale
- Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA
| | - Jayne Pawasauskas
- Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA
| | | |
Collapse
|
23
|
Khodyakov D, Chen C. Nature and Predictors of Response Changes in Modified-Delphi Panels. Value Health 2020; 23:1630-1638. [PMID: 33248519 DOI: 10.1016/j.jval.2020.08.2093] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Revised: 08/14/2020] [Accepted: 08/19/2020] [Indexed: 05/22/2023]
Abstract
OBJECTIVES To describe the extent and nature of changes in participants' responses after exposure to group feedback and discussion in modified-Delphi panels and to identify factors affecting those changes. METHODS We analyzed data from 2 online modified-Delphi panels, each consisting of 2 rating rounds and an online discussion round. We included responses from 55 participants who answered 38 questions in both rating rounds. Because not all participants answered each question twice, our sample consisted of 1846 cases (response changes). We used mixed-effect logistic and multinomial logistic regression to identify factors predicting response changes and their direction relative to group median-our consensus measure. RESULTS Participants changed, on average, 49% of their responses. A response was changed in 47% of the 1846 cases: 28% of responses were changed toward consensus and 19% away from it. Although some measures of subjective participation experiences had a marginally significant impact on the propensity and direction of response changes, several objective measures of discussion engagement were statistically significant predictors of both the presence and direction of response changes. CONCLUSION Our results illustrate the nature of response changes and highlight the importance of exposing participants to alternative perspectives and encouraging them to explain their perspectives.
Collapse
|
24
|
Rudin RS, Fischer SH, Damberg CL, Shi Y, Shekelle PG, Xenakis L, Khodyakov D, Ridgely MS. Optimizing health IT to improve health system performance: A work in progress. Healthc (Amst) 2020; 8:100483. [PMID: 33068915 DOI: 10.1016/j.hjdsi.2020.100483] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 09/18/2020] [Accepted: 09/24/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND Despite significant investments in health information technology (IT), the technology has not yielded the intended performance effects or transformational change. We describe activities that health systems are pursuing to better leverage health IT to improve performance. METHODS We conducted semi-structured telephone interviews with C-suite executives from 24 U.S. health systems in four states during 2017-2019 and analyzed the data using a qualitative thematic approach. RESULTS Health systems reported two broad categories of activities: laying the foundation to improve performance with IT and using IT to improve performance. Within these categories, health systems were engaged in similar activities but varied greatly in their progress. The most substantial effort was devoted to the first category, which enabled rather than directly improved performance, and included consolidating to a single electronic health record (EHR) platform and common data across the health system, standardizing data elements, and standardizing care processes before using the EHR to implement them. Only after accomplishing such foundational activities were health systems able to focus on using the technology to improve performance through activities such as using data and analytics to monitor and provide feedback, improving uptake of evidence-based medicine, addressing variation and overuse, improving system-wide prevention and population health management, and making care more convenient. CONCLUSIONS AND IMPLICATIONS Leveraging IT to improve performance requires significant and sustained effort by health systems, in addition to significant investments in hardware and software. To accelerate change, better mechanisms for creating and disseminating best practices and providing advanced technical assistance are needed.
Collapse
Affiliation(s)
| | | | | | - Yunfeng Shi
- Pennsylvania State University, State College, PA, USA
| | - Paul G Shekelle
- RAND Corporation, Santa Monica, CA, USA; West Los Angeles Veterans Administration, Los Angeles, CA, USA
| | | | | | | |
Collapse
|
25
|
Zia A, Kouides P, Khodyakov D, Dao E, Lavin M, Kadir RA, Othman M, Bauman D, Halimeh S, Winikoff R, Revel-Vilk S. Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCs. J Thromb Haemost 2020; 18:2759-2774. [PMID: 32573942 DOI: 10.1111/jth.14974] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2020] [Revised: 05/19/2020] [Accepted: 06/08/2020] [Indexed: 12/18/2022]
Abstract
BACKGROUND Bleeding disorders (BD) are under-recognized in adolescents with heavy menstrual bleeding (HMB). OBJECTIVES The lack of clinical guidelines and variable symptomatic management of HMB created the imperative to standardize HMB care to identify and manage BD in adolescents. METHODS We convened an international working group (WG), utilized the results of a literature review to define knowledge gaps in HMB care, and used the collective clinical experience of the WG to develop care considerations for adolescents with BD and HMB. We then solicited input on the appropriateness of HMB care considerations from expert stakeholders representing hematology, adolescent medicine, and obstetrics-gynecology. We conducted an expert panel online, using the ExpertLens platform. During a three-round online modified-Delphi process, the expert panel rated the appropriateness of 21 care considerations using a 9-point scale to designate care as appropriate (7-9), uncertain (4-6), or inappropriate (1-3) covering screening for BD, the laboratory work-up, and management of adolescents with BD that present with HMB. We used the RAND/UCLA appropriateness method to determine the existence of consensus among the interdisciplinary panel of experts. RESULTS Thirty-nine experts participated in the panel. The experts rated fifteen HMB care considerations as appropriate, six as uncertain, and none as inappropriate. CONCLUSIONS The HMB care statements represent the first set of HMB care considerations in adolescents with BD, developed with broad expert input on appropriateness. Although likely to be of interest to a range of clinicians who routinely manage adolescents with HMB, additional research is required in many key areas.
Collapse
Affiliation(s)
- Ayesha Zia
- The University of Texas Southwestern Medical Center, Dallas, TX, USA
- Division of Pediatric Hematology Oncology, Children's Health, Dallas, TX, USA
| | - Peter Kouides
- The University of Rochester and the Mary M. Gooley Hemophilia Treatment Center, Rochester, NY, USA
| | | | - Emily Dao
- RAND Corporation, Santa Monica, CA, USA
| | - Michelle Lavin
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Rezan Abdul Kadir
- The Royal Free Foundation Hospital and Institute for Women's Health, University College, London, UK
| | - Maha Othman
- Department of Biomedical and Molecular Sciences, Queen's University Kingston, School of Baccalaureate Nursing, St Lawrence College Kingston, Kingston, ON, Canada
| | - Dvora Bauman
- Department of Pediatric and Adolescent Gynecology, Hadassah University Medical Center, Jerusalem, Israel
| | - Susan Halimeh
- Medical Thrombosis and Haemophilia Treatment Center, Duisburg, Germany
| | - Rochelle Winikoff
- Division of Hematology-Oncology, Sainte-Justine University Health Center, Montréal, Canada
| | - Shoshana Revel-Vilk
- Pediatric Hematology/Oncology Unit, Shaare Zedek Medical Center, Hebrew University Medical School, Jerusalem, Israel
| |
Collapse
|
26
|
Campbell M, Moore G, Evans RE, Khodyakov D, Craig P. ADAPT study: adaptation of evidence-informed complex population health interventions for implementation and/or re-evaluation in new contexts: protocol for a Delphi consensus exercise to develop guidance. BMJ Open 2020; 10:e038965. [PMID: 32690750 PMCID: PMC7375505 DOI: 10.1136/bmjopen-2020-038965] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 05/21/2020] [Accepted: 05/28/2020] [Indexed: 11/16/2022] Open
Abstract
INTRODUCTION Complex population health interventions that are effective in one context may not be effective elsewhere, and may even be harmful. As such, an intervention may require adaptation to ensure it fits with a new context. To date, there is no overarching guidance to help researchers to adapt and evaluate interventions in new contexts, and no criteria to support research funders or journals assess proposed or reported adaptations or evaluation. There is limited assistance for policy-makers and practitioners to decide if evidence-informed interventions are appropriate to their context, or if adaptation and further evaluation is needed. This Delphi exercise will contribute to the development of guidance for these communities to support the adaptation, implementation and/or re-evaluation of complex population health interventions in new contexts. METHODS We will conduct a Delphi consensus exercise to gather expert opinion from researchers, research funders, journal editors and policy-makers. Expert opinion will be sought on: appropriate definitions and concepts, identifying key methodological considerations and establishing adaptations and processes to be undertaken during adaptation of complex population health interventions in new contexts. ETHICS AND DISSEMINATION Ethics approval for the Delphi exercise has been obtained from the University of Glasgow and and the RAND institutional research board. Dissemination of the results of this study will be through peer-reviewed publications, workshops at national and international conferences, and a summary of the guidance developed for key organisations and stakeholders.
Collapse
Affiliation(s)
- Mhairi Campbell
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, UK
| | - Graham Moore
- The Centre for the Development and Evaluation of Complex Public Health Interventions, Cardiff University, Cardiff, South Glamorgan, UK
| | - Rhiannon E Evans
- The Centre for the Development and Evaluation of Complex Public Health Interventions, Cardiff University, Cardiff, South Glamorgan, UK
| | - Dmitry Khodyakov
- Pardee RAND Graduate School, RAND Corp, Santa Monica, California, USA
| | - Peter Craig
- MRC/CSO Social and Public Health Sciences Unit, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, UK
| |
Collapse
|
27
|
Bodnar LM, Khodyakov D, Himes KP, Burke JG, Parisi S, Hutcheon JA. Engaging Patients and Professionals to Evaluate the Seriousness of Maternal and Child Health Outcomes: Protocol for a Modified Delphi Study. JMIR Res Protoc 2020; 9:e16478. [PMID: 32222699 PMCID: PMC7298634 DOI: 10.2196/16478] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 02/19/2020] [Accepted: 03/21/2020] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Maternal weight gain during pregnancy is one of the few potentially modifiable risk factors for many adverse maternal and child health outcomes. Defining the optimal pregnancy weight gain range is difficult because, while lower weight gain may prevent some outcomes, such as maternal and child obesity, it may increase the risk of others such as fetal growth restriction and infant death. These health outcomes vary in their seriousness to mothers and their health care providers, and these differences in seriousness should be taken into account when determining optimal weight gain ranges. However, the relative seriousness that women and their care providers place on different health outcomes is unknown. OBJECTIVE We will determine the seriousness of 11 maternal and child health outcomes that have been consistently associated with pregnancy weight gain. We will achieve this by engaging patients and maternal and child health professionals using an online modified Delphi panel process. METHODS We aim to recruit a racially/ethnically and geographically diverse group of 90 US maternal and child health professionals and 90 women who are pregnant or less than 2 years postpartum. We will conduct 3 concurrent panels using the ExpertLens system, a previously evaluated online modified Delphi system that combines 2 rounds of rating with 1 round of feedback and moderated online discussion. In Round 1, panelists are asked to rate the seriousness of each health outcome on a scale of 0-100 and to provide a rationale for their scores. In Round 2, panelists will review their responses relative to those of other panelists. They will discuss their seriousness ratings anonymously using a moderated online discussion board. In Round 3, participants will revise their Round 1 responses based on group feedback and discussion. Each round will be open for 1-2 weeks. RESULTS The study protocol was reviewed by our ethics boards and did not require approval as human research. A pilot study of 6 professionals and 7 patients was completed in December 2019. CONCLUSIONS Our numeric estimates of the seriousness of maternal and child health outcomes will enable future studies to determine pregnancy weight gain ranges that balance the risks of low and high weight gain for mothers and children. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/16478.
Collapse
Affiliation(s)
- Lisa M Bodnar
- Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States
- Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
- Magee-Womens Research Institute, Pittsburgh, PA, United States
| | | | - Katherine P Himes
- Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
- Magee-Womens Research Institute, Pittsburgh, PA, United States
| | - Jessica G Burke
- Department of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States
| | - Sara Parisi
- Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States
| | - Jennifer A Hutcheon
- Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
28
|
Khodyakov D, Chen C. Response changes in Delphi processes: why is it important to provide high-quality feedback to Delphi participants? J Clin Epidemiol 2020; 125:160-161. [PMID: 32413392 DOI: 10.1016/j.jclinepi.2020.04.029] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/07/2020] [Accepted: 04/08/2020] [Indexed: 12/21/2022]
Affiliation(s)
- Dmitry Khodyakov
- RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, USA.
| | - Christine Chen
- RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, USA
| |
Collapse
|
29
|
Bromley E, Mendoza-Graf A, Berry S, Nebeker C, Khodyakov D. From "Informed" to "Engaged" Consent: Risks and Obligations in Consent for Participation in a Health Data Repository. J Law Med Ethics 2020; 48:172-182. [PMID: 32342789 DOI: 10.1177/1073110520917007] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The development and use of large and dynamic health data repositories designed to support research pose challenges to traditional informed consent models. We used semi-structured interviewing (n=44) to elicit diverse research stakeholders' views of a model of consent appropriate to participation in initiatives that entail collection, long-term storage, and undetermined future research use of multiple types of health data. We demonstrate that, when considering health data repositories, research stakeholders replace a concept of consent as informed with one in which consent is engaged. In engaged consent, a participant's ongoing relationship with a repository serves as a substitute or adjunct to information exchange at enrollment. We detail research stakeholders' views of the risks of engaged consent and suggest questions for further study about engagement and consent procedures in initiatives that aim to store data for future unspecified research purposes.
Collapse
Affiliation(s)
- Elizabeth Bromley
- Elizabeth Bromley, M.D., Ph.D., is Associate Professor in Residence in the Departments of Psychiatry and Anthropology at the University of California, Los Angeles. Alexandra Mendoza-Graf, M.A., is an Assistant Policy Researcher at RAND and Doctoral Fellow at the Pardee RAND Graduate School in Los Angeles, CA. Her research focuses on the social determinants of health. Sandra Berry, M.A., is a senior behavioral scientist at RAND Corporation and senior director of RAND's Survey Research Group. Camille Nebeker, Ph.D., is Director of the Research Center for Optimal Digital Ethics (ReCODE.health) at UC San Diego. Her faculty appointment is with the Division of Behavioral Medicine in the Department of Family Medicine and Public Health at UC San Diego. Dmitry Khodyakov, Ph.D., is a Senior Behavioral/Social Scientist at the RAND Corporation. His research focuses on research ethics, partnered research, stakeholder engagement, and methods of expert elicitation
| | - Alexandra Mendoza-Graf
- Elizabeth Bromley, M.D., Ph.D., is Associate Professor in Residence in the Departments of Psychiatry and Anthropology at the University of California, Los Angeles. Alexandra Mendoza-Graf, M.A., is an Assistant Policy Researcher at RAND and Doctoral Fellow at the Pardee RAND Graduate School in Los Angeles, CA. Her research focuses on the social determinants of health. Sandra Berry, M.A., is a senior behavioral scientist at RAND Corporation and senior director of RAND's Survey Research Group. Camille Nebeker, Ph.D., is Director of the Research Center for Optimal Digital Ethics (ReCODE.health) at UC San Diego. Her faculty appointment is with the Division of Behavioral Medicine in the Department of Family Medicine and Public Health at UC San Diego. Dmitry Khodyakov, Ph.D., is a Senior Behavioral/Social Scientist at the RAND Corporation. His research focuses on research ethics, partnered research, stakeholder engagement, and methods of expert elicitation
| | - Sandra Berry
- Elizabeth Bromley, M.D., Ph.D., is Associate Professor in Residence in the Departments of Psychiatry and Anthropology at the University of California, Los Angeles. Alexandra Mendoza-Graf, M.A., is an Assistant Policy Researcher at RAND and Doctoral Fellow at the Pardee RAND Graduate School in Los Angeles, CA. Her research focuses on the social determinants of health. Sandra Berry, M.A., is a senior behavioral scientist at RAND Corporation and senior director of RAND's Survey Research Group. Camille Nebeker, Ph.D., is Director of the Research Center for Optimal Digital Ethics (ReCODE.health) at UC San Diego. Her faculty appointment is with the Division of Behavioral Medicine in the Department of Family Medicine and Public Health at UC San Diego. Dmitry Khodyakov, Ph.D., is a Senior Behavioral/Social Scientist at the RAND Corporation. His research focuses on research ethics, partnered research, stakeholder engagement, and methods of expert elicitation
| | - Camille Nebeker
- Elizabeth Bromley, M.D., Ph.D., is Associate Professor in Residence in the Departments of Psychiatry and Anthropology at the University of California, Los Angeles. Alexandra Mendoza-Graf, M.A., is an Assistant Policy Researcher at RAND and Doctoral Fellow at the Pardee RAND Graduate School in Los Angeles, CA. Her research focuses on the social determinants of health. Sandra Berry, M.A., is a senior behavioral scientist at RAND Corporation and senior director of RAND's Survey Research Group. Camille Nebeker, Ph.D., is Director of the Research Center for Optimal Digital Ethics (ReCODE.health) at UC San Diego. Her faculty appointment is with the Division of Behavioral Medicine in the Department of Family Medicine and Public Health at UC San Diego. Dmitry Khodyakov, Ph.D., is a Senior Behavioral/Social Scientist at the RAND Corporation. His research focuses on research ethics, partnered research, stakeholder engagement, and methods of expert elicitation
| | - Dmitry Khodyakov
- Elizabeth Bromley, M.D., Ph.D., is Associate Professor in Residence in the Departments of Psychiatry and Anthropology at the University of California, Los Angeles. Alexandra Mendoza-Graf, M.A., is an Assistant Policy Researcher at RAND and Doctoral Fellow at the Pardee RAND Graduate School in Los Angeles, CA. Her research focuses on the social determinants of health. Sandra Berry, M.A., is a senior behavioral scientist at RAND Corporation and senior director of RAND's Survey Research Group. Camille Nebeker, Ph.D., is Director of the Research Center for Optimal Digital Ethics (ReCODE.health) at UC San Diego. Her faculty appointment is with the Division of Behavioral Medicine in the Department of Family Medicine and Public Health at UC San Diego. Dmitry Khodyakov, Ph.D., is a Senior Behavioral/Social Scientist at the RAND Corporation. His research focuses on research ethics, partnered research, stakeholder engagement, and methods of expert elicitation
| |
Collapse
|
30
|
Khodyakov D, Grant S, Denger B, Kinnett K, Martin A, Peay H, Coulter I. Practical Considerations in Using Online Modified-Delphi Approaches to Engage Patients and Other Stakeholders in Clinical Practice Guideline Development. Patient 2020; 13:11-21. [PMID: 31544219 PMCID: PMC6957573 DOI: 10.1007/s40271-019-00389-4] [Citation(s) in RCA: 41] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Patients and caregivers are increasingly recognized as key stakeholders in developing clinical practice guidelines (CPGs). Online engagement approaches offer the promise of a rigorous, scalable, and convenient engagement method. This paper illustrates how an online modified-Delphi approach could be used to engage patients, caregivers, and other stakeholder in CPG development. It provides practical guidance for conducting online modified-Delphi panels that covers (1) joint development of the engagement approach with relevant stakeholders, (2) adaptation of methods used by experts in guideline development, (3) pilot testing, (4) participant recruitment, (5) determining panel size and composition, (6) building participant capacity, (7) facilitation of two-way interaction, (8) continuous engagement and retention of participants, (9) rigorous data analysis, (10) evaluation of engagement activities, and (11) result dissemination. The paper is based on a recently completed study about engaging individuals with Duchenne muscular dystrophy (DMD) and their caregivers in determining the patient-centeredness of DMD care guidelines.
Collapse
Affiliation(s)
- Dmitry Khodyakov
- RAND Health Care, RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA USA
| | - Sean Grant
- RAND Health Care, RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA USA
- Indiana University, Richard M. Fairbanks School of Public Health, Indianapolis, IN USA
| | - Brian Denger
- Parent Project Muscular Dystrophy, Hackensack, NJ USA
| | - Kathi Kinnett
- Parent Project Muscular Dystrophy, Hackensack, NJ USA
| | - Ann Martin
- Parent Project Muscular Dystrophy, Hackensack, NJ USA
| | - Holly Peay
- RTI International, Research Triangle Park, NC USA
| | - Ian Coulter
- RAND Health Care, RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA USA
| |
Collapse
|
31
|
Khodyakov D, Grant S, Denger B, Kinnett K, Martin A, Booth M, Armstrong C, Dao E, Chen C, Coulter I, Peay H, Hazlewood G, Street N. Using an Online, Modified Delphi Approach to Engage Patients and Caregivers in Determining the Patient-Centeredness of Duchenne Muscular Dystrophy Care Considerations. Med Decis Making 2019; 39:1019-1031. [PMID: 31722623 PMCID: PMC6900571 DOI: 10.1177/0272989x19883631] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Accepted: 09/21/2019] [Indexed: 12/30/2022]
Abstract
Purpose. To determine the patient-centeredness of endocrine and bone health Duchenne muscular dystrophy (DMD) care considerations using the RAND/PPMD Patient-Centeredness Method (RPM), which is a novel, online, modified-Delphi approach to engaging patients and caregivers in clinical guideline development. Methods. We solicited input on the patient-centeredness of care considerations from 28 individuals with DMD and 94 caregivers, randomly assigned to 1 of 2 mixed panels. During a 3-round online modified-Delphi process, participants rated the importance and acceptability of 19 DMD care considerations (round 1), reviewed and discussed the initial results (round 2), and revised their original ratings (round 3). Patient-centeredness was operationalized as importance and acceptability of recommendations. We considered a care consideration to be patient-centered if both panels deemed it important and acceptable. Results. Ninety-five panelists (78%) participated in this study. Of these, 88 (93%) participated in round 1, 74 (78%) in round 2, and 56 (59%) in round 3. Panelists deemed 12 care considerations to be patient-centered: 3 weight management, 3 bone health, 4 vertical growth, and 2 puberty recommendations. Seven care considerations did not meet patient-centeredness criteria. Common reasons were lack of evidence specific to DMD and concerns about insurance coverage, access to treatment, and patient safety. Conclusions. Using the RPM, Duchenne families considered most care considerations to be patient-centered. Besides being clinically appropriate, these considerations are likely to be consistent with the preferences, needs, and values of Duchenne families. While all relevant care considerations should be discussed during patient-provider encounters, those that did not meet patient-centeredness criteria in particular should be carefully considered as part of joint decision making between Duchenne families and their providers. Study Registration: HSRProj 20163126.
Collapse
Affiliation(s)
| | - Sean Grant
- />RAND Health Care, Santa Monica, CA, USA
- />Department of Social & Behavioral Sciences,
Indiana University Richard M. Fairbanks School of Public Health,
Indianapolis, IN, USA
| | - Brian Denger
- Parent Project Muscular Dystrophy, Hackensack,
NJ, USA
| | - Kathi Kinnett
- Parent Project Muscular Dystrophy, Hackensack,
NJ, USA
| | - Ann Martin
- Parent Project Muscular Dystrophy, Hackensack,
NJ, USA
| | | | | | | | | | | | - Holly Peay
- RTI International, Research Triangle Park, NC,
USA
| | - Glen Hazlewood
- Department of Medicine, Cumming School of
Medicine, University of Calgary, Calgary, AB, Canada
| | - Natalie Street
- Centers for Disease Control and Prevention,
National Center on Birth Defects and Developmental Disabilities, Atlanta,
GA, USA
| |
Collapse
|
32
|
Abstract
Background: There is a growing interest in creating large-scale repositories that store genetic, behavioral, and environmental data for future, unspecified uses. The All of Us Research Program is one example of such a repository. Its participants will get access to their personal data and the results of the studies that used them. However, little is known about what researchers should return to participants and how they should do it in a way that is valuable and meaningful to participants. Methods: To better understand the concept of "return of value" and the practice of returning valuable study information, we conducted semi-structured telephone interviews with 44 stakeholders with diverse perspectives on this topic. All interviews have been transcribed and coded thematically to identify the most salient themes, to explore differences between returning different types of study results, and to describe differences and similarities in perspectives of different stakeholder groups. Results: We found that one size does not fit all when it comes to returning value to participants: the decisions about return of results are affected by participant preferences, researchers' concerns about feasibility, the types of data collected, their level of granularity, and available options for supporting result interpretation. Conclusions: Our findings suggest that the key to operationalizing return of value and to identifying ways to return valuable information to study participants may be to find a point of equilibrium between criteria that may affect usefulness and feasibility. The point of equilibrium may vary by study, by participants' backgrounds and preferences, by their health literacy and access to regular healthcare, and by the resources available to professionals controlling the data. Future studies should explore the factors that determine the point of equilibrium between feasibility and usefulness.
Collapse
|
33
|
Denger B, Kinnett K, Martin A, Grant S, Armstrong C, Khodyakov D. Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy. Orphanet J Rare Dis 2019; 14:205. [PMID: 31429780 PMCID: PMC6702715 DOI: 10.1186/s13023-019-1173-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2019] [Accepted: 08/13/2019] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Clinical care guidelines are typically developed by clinicians and researchers. Including patient and caregiver voices in guideline development may help create guidelines that are more useful for patients and consequently improve their guideline adherence. Although there is substantial research on the factors the affect providers' adherence to guidelines, there is less research on the factors that affect patients' compliance with guideline recommendations, especially among those with rare disorders. The purpose of this study is to explore factors that are likely to affect patient/caregiver adherence to endocrine and bone health recommendations for Duchenne Muscular Dystrophy (DMD). To do so, we used qualitative data collected as part of the study designed to develop, implement, and evaluate a new online, modified-Delphi approach to engaging patients with rare diseases and their caregivers in guideline development, using care guidelines for DMD as a case study. METHODS We thematically analyzed qualitative data collected from 95 adults with DMD and their caregivers who participated in at least one round of our online Modified-Delphi panel process. Participants rated and commented on the patient-centeredness of 19 recommendations about vertical growth, weight management, bone health, and delayed puberty included in the 2018 DMD care considerations. Patient-centeredness was operationalized as the importance and acceptability of care recommendations. RESULTS Thematic analyses revealed six factors that affect guideline adherence from the patient/caregiver perspective: content and format of recommendations, patient and provider characteristics, and social and financial factors. CONCLUSIONS This study used a novel approach to exploring patient and caregiver perspectives on factors that may affect guideline adherence. The six factors identified by DMD patients and caregivers are similar to the factors affecting provider adherence and are not limited to DMD. Understanding consistency between provider- and patient/caregiver-identified barriers to following guideline recommendations can lead to developing more successful interventions for increasing guideline adherence.
Collapse
Affiliation(s)
- Brian Denger
- Parent Project Muscular Dystrophy, 401 Hackensack Avenue, 9th Floor, Hackensack, NJ, 07601, USA
| | - Kathi Kinnett
- Parent Project Muscular Dystrophy, 401 Hackensack Avenue, 9th Floor, Hackensack, NJ, 07601, USA
| | - Ann Martin
- Parent Project Muscular Dystrophy, 401 Hackensack Avenue, 9th Floor, Hackensack, NJ, 07601, USA
| | - Sean Grant
- RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, 90407-2138, USA.,Department of Social & Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, 1050 Wishard Blvd, RG 6046, Indianapolis, 46202, IN, USA
| | - Courtney Armstrong
- RAND Corporation, 1885 Mission Street, Suite 300, San Francisco, CA, 94103, USA
| | - Dmitry Khodyakov
- RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, 90407-2138, USA.
| |
Collapse
|
34
|
Khodyakov D, Buttorff C, Bouskill K, Armstrong C, Ma S, Taylor EA, Eibner C. Insurers' perspectives on MA value-based insurance design model. Am J Manag Care 2019; 25:e198-e203. [PMID: 31318510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVES Value-based insurance design (VBID) lowers cost sharing for high-value healthcare services that are clinically beneficial to patients with certain conditions. In 2017, the Center for Medicare and Medicaid Innovation began a voluntary VBID model test in Medicare Advantage (MA). This article describes insurers' perspectives on the MA VBID model, explores perceived barriers to joining this model, and describes ways to address participation barriers. STUDY DESIGN A descriptive, qualitative study. METHODS In spring/summer 2017, we conducted semistructured interviews with 24 representatives of 10 nonparticipating MA insurers to learn why they did not join the model test. We interviewed 73 representatives of 8 VBID-participating insurers about their participation decisions and implementation experiences. All interview data were analyzed thematically. RESULTS Fewer than 30% of eligible insurers participated in the first 2 years of the model test. The main barriers to entry were a perceived lack of information on VBID in MA, an expectation of low return on investment, concerns over administrative and information technology (IT) hurdles, and model design parameters. Most VBID participants encountered administrative and IT hurdles but overcame them. CMS made changes to the model parameters to increase the uptake. CONCLUSIONS The model uptake was low, and implementation challenges and concerns over VBID effectiveness in the Medicare population were important factors in participation decisions. To increase uptake, CMS could consider providing in-kind implementation assistance to model participants. Nonparticipants may want to incorporate lessons learned from current participants, and insurers should engage their IT departments/vendors early on.
Collapse
|
35
|
Armstrong C, Grant S, Kinnett K, Denger B, Martin A, Coulter I, Booth M, Khodyakov D. Participant experiences with a new online modified-Delphi approach for engaging patients and caregivers in developing clinical guidelines. Eur J Pers Cent Healthc 2019; 7:476-489. [PMID: 34422276 PMCID: PMC8375559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
BACKGROUND Patient engagement in clinical practice guideline (CPG) development has increased significantly in recent years. However, only a few patients and caregivers join CPG development groups. OBJECTIVE To describe participant experiences with a novel online, scalable approach for patient and caregiver engagement in CPG development. DESIGN We developed and tested the RAND/PPMD Patient-Centeredness Method (RPM), a novel online modified-Delphi approach to patient engagement in CPG development that consists of an optional idea generation round and two rating rounds interspersed with an online discussion round. SETTING AND PARTICIPANTS Using the online ExpertLens™ system, we ran 2 concurrent panels of patients and caregivers of individuals with Duchenne Muscular Dystrophy (DMD). MAIN OUTCOME MEASURES We surveyed all 95 panel participants about their participation and satisfaction with the process. We also conducted telephone interviews with 25 participants. RESULTS Participants expressed satisfaction with various ExpertLens™ features, noting that the system fostered lively interaction among them. Panelists also appreciated participating in an educational, interactive and convenient discussion forum that allowed them to share their opinions on the importance and acceptability of different recommendations. The RPM was viewed as empowering by patients and their caregivers who felt it would be useful for CPG developers. DISCUSSION AND CONCLUSION The results of our study show the overall participant satisfaction with a novel, scalable, online approach to engaging patients and caregivers in CPG development, which allows them to share their perspectives and lived experiences using a rigorous, systematic and iterative way that is similar to how clinicians provide their input.
Collapse
Affiliation(s)
- Courtney Armstrong
- Policy Analyst, RAND Health Care, RAND Corporation, San Francisco, CA, USA
| | - Sean Grant
- Assistant Professor, Department of Social & Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN, USA; Adjunct Behavioral/Social Scientist, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| | - Kathi Kinnett
- Senior Vice President, Clinical Care, Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Brian Denger
- Collaborative Programs Administrator, Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Ann Martin
- Director, The Duchenne Registry, Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Ian Coulter
- Policy Researcher, Adjunct, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| | - Marika Booth
- Statistical Analyst, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| | - Dmitry Khodyakov
- Senior Behavioral/Social Scientist, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| |
Collapse
|
36
|
Khodyakov D, Denger B, Grant S, Kinnett K, Armstrong C, Martin A, Peay H, Coulter I, Hazlewood G. The RAND/PPMD Patient-Centeredness Method: a novel online approach to engaging patients and their representatives in guideline development. Eur J Pers Cent Healthc 2019; 7:470-475. [PMID: 34277012 PMCID: PMC8281319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
Although clinical practice guidelines (CPGs) provide recommendations for how best to treat a typical patient with a given condition, patients and their representatives are not always engaged in CPG development. Despite the agreement that patient participation may improve the quality and utility of CPGs, there is no systematic, scalable method for engaging patients and their representatives, as well as no consensus on what exactly patients and their representatives should be asked to do during CPG development. To address these gaps, an interdisciplinary team of researchers, patient representatives, and clinicians developed the RAND/PPMD Patient-Centeredness Method (RPM) - a novel online approach to engaging patients and their representatives in CPG development. The RPM is an iterative approach that allows patients and their representatives to provide input by (1) generating ideas; (2) rating draft recommendations on two criteria (importance and acceptability); (3) explaining and discussing their ratings with other participants using online, asynchronous, anonymous, moderated discussion boards, and (4) revising their responses if needed. The RPM was designed to be consistent with the RAND/UCLA Appropriateness Method used by clinicians and researchers to develop CPG, while helping patients and their representative rate outcome importance and recommendation acceptability - two key components of the GRADE Evidence to Decision (EtD) framework. With slight modifications, the RPM has the potential to explore consensus among key stakeholders on other dimensions of the EtD, including feasibility, equity, and resource use.
Collapse
Affiliation(s)
- Dmitry Khodyakov
- Senior Behavioral/Social Scientist, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| | - Brian Denger
- Collaborative Programs Administrator, Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Sean Grant
- Assistant Professor, Department of Social & Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN & Adjunct Behavioral/Social Scientist, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| | - Kathi Kinnett
- Senior Vice President, Clinical Care, Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Courtney Armstrong
- Policy Analyst, RAND Health Care, RAND Corporation, San Francisco, CA, USA
| | - Ann Martin
- Director, The Duchenne Registry, Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Holly Peay
- Senior Research Public Health Analyst, RTI International, Raleigh, NC, USA
| | - Ian Coulter
- Policy Researcher, Adjunct, RAND Health Care, RAND Corporation, Santa Monica, CA, USA
| | - Glen Hazlewood
- Assistant Professor, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
| |
Collapse
|
37
|
Grant S, Hazlewood GS, Peay HL, Lucas A, Coulter I, Fink A, Khodyakov D. Practical Considerations for Using Online Methods to Engage Patients in Guideline Development. Patient 2018; 11:155-166. [PMID: 29030831 DOI: 10.1007/s40271-017-0280-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Clinical practice guidelines (CPGs) have been widely used in healthcare policy, practice, and for suggesting future research. As patients increasingly become involved in CPG development to produce patient-centered recommendations, more research is needed on methods to engage patients, particularly methods allowing for scalable engagement of large, diverse, and geographically distributed groups of patients. In this article, we discuss practical considerations for using online methods to engage patients in CPG development. To inform this discussion, we conducted a rapid, systematic review of literature on patient involvement in CPG development and used qualitative evidence synthesis techniques to make inferences about potential advantages and challenges of using online methods to engage patients in this context. We identified 79 articles containing information about involving patients in CPG development. Potential advantages include the ability of online methods to facilitate greater openness and honesty by patients, as well as to reflect the diversity of patient views, which in turn further improve the utility of CPGs. Potential challenges of using online methods may include the extra skill, time, and certain types of resources that may be needed for patient engagement, as well as the difficulty engaging specific patient populations. However, these challenges are mitigated by growing calls for patient engagement as normative for CPG development in addition to patients' increasing familiarity with online technologies. These practical considerations should be examined empirically as guideline development groups further explore the appropriateness of using online methods to engage patients across different stages of CPG development.
Collapse
Affiliation(s)
- Sean Grant
- Behavioral and Policy Sciences Department, RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, 90407-2138, USA.
| | - Glen S Hazlewood
- Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
| | - Holly L Peay
- RTI International, Research Triangle Park, NC, USA
| | - Ann Lucas
- Parent Project Muscular Dystrophy, Hackensack, NJ, USA
| | - Ian Coulter
- Economics, Sociology, and Statistics Department, RAND Corporation, Santa Monica, CA, USA
| | - Arlene Fink
- David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA
| | - Dmitry Khodyakov
- Behavioral and Policy Sciences Department, RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, CA, 90407-2138, USA
| |
Collapse
|
38
|
Khodyakov D, Sharif MZ, Jones F, Heller SM, Pulido E, Wells KB, Bromley E. Whole Person Care in Under-resourced Communities: Stakeholder Priorities at Long-Term Follow-Up in Community Partners in Care. Ethn Dis 2018; 28:371-380. [PMID: 30202190 DOI: 10.18865/ed.28.s2.371] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Objective Depressed individuals may require help from different agencies to address health and social needs, but how such coordination occurs in under-resourced communities is poorly understood. This study sought to identify priorities of Latino and African American depressed clients, explore whether service providers understand client priorities, and describe how providers address them. Methods Between October 2014 and February 2015, we interviewed 104 clients stratified by depression history and 50 representatives of different programs in health and social community agencies who participated in Community Partners in Care, a cluster-randomized trial of coalition-building approaches to delivering depression quality improvement programs. Clients were queried about their most pressing needs; program representatives identified their clients' needs and explained how they addressed them. Results Physical and mental health were clients' top priorities, followed by housing, caring for and building relationships with others, and employment. While persistently depressed clients prioritized mental health, those with improved depression prioritized relationships with others. Program representatives identified housing, employment, mental health, and improving relationships with others as clients' top priorities. Needs assessment, client-centered services, and linkages to other agencies were main strategies used to address client needs. Conclusion Depressed clients have multiple health and social needs, and program representatives in under-resourced communities understand the complexity of clients' needs. Agencies rely on needs assessment and referrals to meet their clients' needs, which enhances the importance of agency partnership in "whole person" initiatives. Our results illustrate agency capacity to adopt integrated care models that will address clients' multiple needs through multi-sector collaboration and describe potential strategies to help reach the goal of whole person care.
Collapse
Affiliation(s)
| | | | - Felica Jones
- Healthy African American Families II, Los Angeles, CA
| | - S Megan Heller
- Center for Health Services and Society, University of California, Los Angeles, CA
| | | | - Kenneth B Wells
- Center for Health Services and Society, University of California, Los Angeles, David Geffen School of Medicine, Department of Psychiatry & Biobehavioral Sciences; RAND Corporation; University of California, Los Angeles School of Public Health
| | - Elizabeth Bromley
- Center for Health Services and Society, University of California, Los Angeles, David Geffen School of Medicine, Department of Psychiatry & Biobehavioral Sciences; Desert Pacific MIRECC Health Services Unit, VA Greater Los Angeles Healthcare System, Los Angeles, CA
| |
Collapse
|
39
|
Grant S, Booth M, Khodyakov D. Lack of preregistered analysis plans allows unacceptable data mining for and selective reporting of consensus in Delphi studies. J Clin Epidemiol 2018; 99:96-105. [PMID: 29559324 DOI: 10.1016/j.jclinepi.2018.03.007] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2017] [Revised: 02/02/2018] [Accepted: 03/10/2018] [Indexed: 02/06/2023]
Abstract
OBJECTIVES To empirically demonstrate how undisclosed analytic flexibility provides substantial latitude for data mining and selective reporting of consensus in Delphi processes. STUDY DESIGN AND SETTING Pooling data across eight online modified-Delphi panels, we first calculated the percentage of items reaching consensus according to descriptive analysis procedures commonly used in health research but selected post hoc in this article. We then examined the variability of items reaching consensus across panels. RESULTS Pooling all panel data, the percentage of items reaching consensus ranged from 0% to 84%, depending on the analysis procedure. Comparing data across panels, variability in the percentage of items reaching consensus for each analysis procedure ranged from 0 (i.e., all panels had the same percentage of items reaching consensus for a given analysis procedure) to 83 (i.e., panels had a range of 11% to 94% of items reaching consensus for a given analysis procedure). Of 200 total panel-by-analysis-procedure configurations, four configurations (2%) had all items and 64 (32%) had no items reaching consensus. CONCLUSION Undisclosed analytic flexibility makes it unacceptably easy to data mine for and selectively report consensus in Delphi processes. As a solution, we recommend prospective, complete registration of preanalysis plans for consensus-oriented Delphi processes in health research.
Collapse
Affiliation(s)
- Sean Grant
- RAND Corporation, 1776 Main Street, Santa Monica, CA 90401, USA.
| | - Marika Booth
- RAND Corporation, 1776 Main Street, Santa Monica, CA 90401, USA
| | | |
Collapse
|
40
|
Leyenaar JK, Rizzo PA, Khodyakov D, Leslie LK, Lindenauer PK, Mangione-Smith R. Importance and Feasibility of Transitional Care for Children With Medical Complexity: Results of a Multistakeholder Delphi Process. Acad Pediatr 2018; 18:94-101. [PMID: 28739535 PMCID: PMC5756674 DOI: 10.1016/j.acap.2017.07.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2017] [Revised: 07/14/2017] [Accepted: 07/18/2017] [Indexed: 11/19/2022]
Abstract
BACKGROUND Children with medical complexity (CMC) account for disproportionate hospital utilization and adverse outcomes after discharge, and several gaps exist regarding the quality of hospital to home transitional care for this population. We conducted an expert elicitation process to identify important and feasible hospital to home transitional care interventions for CMC from the perspectives of parents and health care professionals. METHODS We conducted a 2-round electronic Delphi process to identify important and feasible transitional care interventions. Panelists included parents of CMC and multidisciplinary health care professionals. In the first round, panelists rated the importance and feasibility of 39 transitional care interventions on a 9-point Likert scale; agreement between panelists was defined according to RAND/UCLA Appropriateness Methods. The second round of data collection evaluated 16 interventions that panelists did not agree on in the first round and 8 new or revised interventions, accompanied by quantitative and qualitative data summaries. RESULTS A total of 29 parents of CMC and 37 health care professionals participated in the Delphi process (response rate 75%). Both stakeholder panels endorsed most interventions as important; health care professionals were less likely to rate several interventions as feasible compared with the parent panel. Over 2 rounds of data collection, the 2 stakeholder panels endorsed 25 interventions as important as well as feasible. These interventions related to family engagement during the hospitalization, care coordination and social support assessment, predischarge education, and written materials. CONCLUSIONS Parents and health care professionals considered several transitional care interventions important as well as feasible. This research might inform hospitals' transitional care programs and policies.
Collapse
Affiliation(s)
- JoAnna K Leyenaar
- Division of Pediatric Hospital Medicine, Department of Pediatrics, Tufts University School of Medicine, Boston, Mass.
| | | | | | - Laurel K Leslie
- Departments of Medicine and Pediatrics, Tufts Medical Center, Boston, Mass; Department of Research, American Board of Pediatrics, Chapel Hill, NC
| | - Peter K Lindenauer
- Department of Quantitative Health Sciences, University of Massachusetts Medial School, Worcester; Institute for Healthcare Delivery and Population Science and Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield
| | - Rita Mangione-Smith
- Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle
| |
Collapse
|
41
|
Ong MK, Jones L, Aoki W, Belin TR, Bromley E, Chung B, Dixon E, Johnson MD, Jones F, Koegel P, Khodyakov D, Landry CM, Lizaola E, Mtume N, Ngo VK, Perlman J, Pulido E, Sauer V, Sherbourne CD, Tang L, Vidaurri E, Whittington Y, Williams P, Lucas-Wright A, Zhang L, Southard M, Miranda J, Wells K. A Community-Partnered, Participatory, Cluster-Randomized Study of Depression Care Quality Improvement: Three-Year Outcomes. Psychiatr Serv 2017; 68:1262-1270. [PMID: 28712349 PMCID: PMC5711579 DOI: 10.1176/appi.ps.201600488] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Community Partners in Care, a community-partnered, cluster-randomized trial with depressed clients from 93 Los Angeles health and community programs, examined the added value of a community coalition approach (Community Engagement and Planning [CEP]) versus individual program technical assistance (Resources for Services [RS]) for implementing depression quality improvement in underserved communities. CEP was more effective than RS in improving mental health-related quality of life, reducing behavioral health hospitalizations, and shifting services toward community-based programs at six months. At 12 months, continued evidence of improvement was found. This study examined three-year outcomes. METHODS Among 1,004 participants with depression who were eligible for three-year follow-up, 600 participants from 89 programs completed surveys. Multiple regression analyses estimated intervention effects on poor mental health-related quality of life and depression, physical health-related quality of life, behavioral health hospital nights, and use of services. RESULTS At three years, no differences were found in the effects of CEP versus RS on depression or mental health-related quality of life, but CEP had modest effects in improving physical health-related quality of life and reducing behavioral health hospital nights, and CEP participants had more social- and community-sector depression visits and greater use of mood stabilizers. Sensitivity analyses with longitudinal modeling reproduced these findings but found no significant differences between groups in change from baseline to three years. CONCLUSIONS At three years, CEP and RS did not have differential effects on primary mental health outcomes, but CEP participants had modest improvements in physical health and fewer behavioral health hospital nights.
Collapse
Affiliation(s)
- Michael K Ong
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Loretta Jones
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Wayne Aoki
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Thomas R Belin
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Elizabeth Bromley
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Bowen Chung
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Elizabeth Dixon
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Megan Dwight Johnson
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Felica Jones
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Paul Koegel
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Dmitry Khodyakov
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Craig M Landry
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Elizabeth Lizaola
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Norma Mtume
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Victoria K Ngo
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Judith Perlman
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Esmeralda Pulido
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Vivian Sauer
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Cathy D Sherbourne
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Lingqi Tang
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Ed Vidaurri
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Yolanda Whittington
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Pluscedia Williams
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Aziza Lucas-Wright
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Lily Zhang
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Marvin Southard
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Jeanne Miranda
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| | - Kenneth Wells
- Dr. Ong is with the Department of Medicine; Dr. Belin is with the Department of Biostatistics; Dr. Bromley, Dr. Landry, Ms. Lizaola, Ms. Williams, Ms. Zhang, Dr. Miranda, and Dr. Wells are with the Center for Health Services and Society, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; Dr. Chung and Dr. Tang are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine; and Dr. Dixon is with the School of Nursing, all at the University of California, Los Angeles (UCLA), Los Angeles. Dr. Ong is also with the Department of Medicine, Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, West Los Angeles VA Healthcare System, Los Angeles. Ms. Williams is also with Healthy African American Families II, Los Angeles, where Dr. Jones and Ms. Jones are affiliated. Dr. Wells is also with RAND Health, RAND Corporation, Santa Monica, California, where Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, and Dr. Sherbourne are affiliated. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanente of Southern California, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer is with Jewish Family Services of Los Angeles, Los Angeles. Mr. Vidaurri and Ms. Whittington are with the Los Angeles County Department of Mental Health, Los Angeles. Ms. Lucas-Wright is with the UCLA Clinical and Translational Science Institute and the Charles R. Drew University of Medicine and Science, both in Los Angeles. Dr. Southard is with the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles
| |
Collapse
|
42
|
Sherbourne CD, Aoki W, Belin TR, Bromley E, Chung B, Dixon E, Gilmore JM, Johnson MD, Jones F, Koegel P, Khodyakov D, Landry CM, Lizaola E, Mtume N, Ngo VK, Ong MK, Perlman J, Pulido E, Sauer V, Tang L, Whittington Y, Vidaurri E, Williams P, Lucas-Wright A, Zhang L, Miranda J, Jones L, Wells K. Comparative Effectiveness of Two Models of Depression Services Quality Improvement in Health and Community Sectors. Psychiatr Serv 2017; 68:1315-1320. [PMID: 29089009 PMCID: PMC5872839 DOI: 10.1176/appi.ps.201700170] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE The effectiveness of community coalition building and program technical assistance was compared in implementation of collaborative care for depression among health care and community sector clients. METHODS In under-resourced communities, within 93 programs randomly assigned to coalition building (Community Engagement and Planning) or program technical assistance (Resources for Services) models, 1,018 clients completed surveys at baseline and at six, 12, or 36 months. Regression analysis was used to estimate intervention effects and intervention-by-sector interaction effects on depression, mental health-related quality of life, and community-prioritized outcomes and on services use. RESULTS For outcomes, there were few significant intervention-by-sector interactions, and stratified findings suggested benefits of coalition building in both sectors. For services use, at 36 months, increases were found for coalition building in primary care visits, self-help visits, and appropriate treatment for community clients and in community-based services use for health care clients. CONCLUSIONS Relative to program technical assistance, community coalition building benefited clients across sectors and shifted long-term utilization across sectors.
Collapse
Affiliation(s)
- Cathy D Sherbourne
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Wayne Aoki
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Thomas R Belin
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Elizabeth Bromley
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Bowen Chung
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Elizabeth Dixon
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - James M Gilmore
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Megan Dwight Johnson
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Felica Jones
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Paul Koegel
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Dmitry Khodyakov
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Craig M Landry
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Elizabeth Lizaola
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Norma Mtume
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Victoria K Ngo
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Michael K Ong
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Judith Perlman
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Esmeralda Pulido
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Vivian Sauer
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Lingqi Tang
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Yolanda Whittington
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Ed Vidaurri
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Pluscedia Williams
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Aziza Lucas-Wright
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Lily Zhang
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Jeanne Miranda
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Loretta Jones
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| | - Kenneth Wells
- Dr. Sherbourne, Dr. Koegel, Dr. Khodyakov, Dr. Ngo, Ms. Perlman, Ms. Lucas-Wright, and Dr. Wells are with RAND Health, RAND Corporation, Santa Monica, California. Dr. Wells, along with Dr. Bromley, Dr. Chung, Dr. Landry, and Dr. Miranda, is also with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA). Dr. Bromley is also with the Desert Pacific Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles. Dr. Aoki is with Los Angeles Christian Health Centers, Los Angeles. Dr. Belin is with the Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles. Dr. Dixon is with the School of Nursing, UCLA. Mr. Gilmore is with Behavioral Health Services, Los Angeles. Dr. Johnson is with the Department of Psychiatry, Kaiser Permanent of Southern California, Los Angeles. Ms. Jones, Ms. Williams, and Dr. Jones are with Healthy African American Families II, Los Angeles. Ms. Lizaola, Dr. Tang, and Ms. Zhang are with the Semel Institute Center for Health Services and Society, UCLA, Los Angeles. Ms. Mtume is with Shields for Families, Los Angeles. Dr. Ong is with the Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles. Ms. Pulido is with L.A. Care Health Plan, Los Angeles. Ms. Sauer, now retired, was with Jewish Family Services of Los Angeles at the time of this study. Ms. Whittington is with the Los Angeles County Department of Mental Health, Los Angeles, where Mr. Vidaurri was affiliated before his retirement
| |
Collapse
|
43
|
Barber CEH, Mosher DP, Ahluwalia V, Zummer M, Marshall DA, Choquette D, Lacaille D, Bombardier C, Lyddiatt A, Chandran V, Khodyakov D, Dao E, Barnabe C. Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis. J Rheumatol 2017; 44:1813-1822. [PMID: 28966205 DOI: 10.3899/jrheum.170421] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/14/2017] [Indexed: 12/14/2022]
Abstract
OBJECTIVE To develop a Canadian Rheumatoid Arthritis Core Clinical Dataset (CAN-RACCD) to standardize documentation encouraging high-quality care. METHODS A set of candidate elements was drafted through meetings with 27 rheumatologists, researchers, and patients, and supplemented with focused literature reviews. A 3-round online-modified Delphi consensus process was held with rheumatologists (n = 26), allied health professionals (n = 7), and patients (n = 4); for the remainder there was no demographic information. Participants rated both the importance and feasibility of documenting candidate elements on a Likert scale of 1-9, contributed to an online moderated discussion, and re-rated the elements for inclusion in the CAN-RACCD. Elements were included in the final set if importance and feasibility ratings had a median score of ≥ 6.5 and there was no disagreement among participants. RESULTS Fifty-five individual elements in 10 subgroups were proposed to the Delphi participants: measures of RA disease activity; dates to calculate waiting times, disease duration, and disease-modifying antirheumatic drug start; comorbidities; smoking status; patient-reported pain and fatigue; physical function; laboratory and radiographic investigations; medications; clinical characteristics; and vaccines. All groups were included in the final set, with the exception of vaccination status. Additionally, 3 individual elements from the smoking subgroup were eliminated with a recommendation to record smoking status as never/ever/current, and 2 elements relating to coping and effect of fatigue were eliminated due to low feasibility and importance ratings. CONCLUSION The CAN-RACCD stands as a national recommendation on which data elements should be routinely collected in clinical practice to monitor and support high-quality RA care.
Collapse
Affiliation(s)
- Claire E H Barber
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA. .,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary.
| | - Dianne P Mosher
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Vandana Ahluwalia
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Michel Zummer
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Deborah A Marshall
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Denis Choquette
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Diane Lacaille
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Claire Bombardier
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Anne Lyddiatt
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Vinod Chandran
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Dmitry Khodyakov
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | - Emily Dao
- From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences of the Cumming School of Medicine, and the McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, and the Department of Medicine and Laboratory Medicine and Pathobiology, and the Institute of Medical Science, and the Krembil Research Institute, University of Toronto, Toronto; Arthritis Alliance of Canada (AAC) Inflammatory Arthritis Models of Care, Toronto; William Osler Health System, Brampton; Canadian Institute of Health Research (CIHR) National Steering Committee, Ottawa; Outcome Measures in Rheumatology (OMERACT), Ottawa, Ontario; Hôpital Maisonneuve-Rosemont, and the Institut de Recherche en Rhumatologie de Montréal, Université de Montréal, Montreal, Quebec, Canada; RAND Corp., Santa Monica, California, USA.,C.E. Barber, MD, FRCPC, PhD, Assistant Professor, Division of Rheumatology, departments of Medicine and Community Health Sciences, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health, Research Scientist, Arthritis Research Canada; D.P. Mosher, MD, FRCPC, Professor, Chief, Division of Rheumatology, Department of Medicine, University of Calgary; V. Ahluwalia, MD, FRCPC, Consultant Rheumatologist, William Osler Health System; M. Zummer, MD, FRCPC, Chief, Rheumatology, Hôpital Maisonneuve-Rosemont, Associate Professor, Université de Montréal; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, Canada Research Chair (Health Services and Systems Research), Arthur J.E. Child Chair in Rheumatology Research, Department of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health, and Arthritis Research Canada; D. Choquette, MD, FRCPC, Institut de Recherche en Rhumatologie de Montréal, Scientific Director, Rhumadata, Université de Montréal; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia, Senior Scientist, Arthritis Research Canada; C. Bombardier, MD, FRCPC, Professor, Division of Rheumatology, University of Toronto; A. Lyddiatt, member, CIHR National Steering Committee, OMERACT patient research partner, AAC Inflammatory Arthritis Models of Care Executive Member; V. Chandran, MBBS, MD, DM, PhD, Assistant Professor, Department of Medicine and Laboratory Medicine and Pathobiology, Institute of Medical Science, Krembil Research Institute; D. Khodyakov, PhD, MA, BA, Senior Behavioral/Social Scientist, RAND Corp.; E. Dao, BS, RAND Corp.; C. Barnabe, MD, MSc, FRCPC, Associate Professor, departments of Medicine and Community Health Sciences, University of Calgary
| | | | | |
Collapse
|
44
|
Abstract
Participatory researchers rely on relationship-based ethical considerations to address ethical challenges, but little is known about how these considerations shape day-to-day decision-making. We presented vignettes describing ethical dilemmas to health researchers with varying degrees of experience in participatory research in an online modified-Delphi panel. Panelists rated potential solutions to dilemmas and provided rationales for choosing solutions in text boxes and discussion boards. Panelists agreed on a preferred solution for three of five vignettes. Panelists indicated that ethical research decision-making should be inclusive of diverse perspectives. Panelists prioritized scientific goals above participatory ones and viewed tenets of scientific validity as value-free. Panelists indicated that participatory research ethics would be difficult to codify, but that vignette-based learning could support didactic objectives.
Collapse
Affiliation(s)
- Elizabeth Bromley
- 1 University of California, Los Angeles, CA, USA.,2 West Los Angeles VA Healthcare Center, CA, USA
| | | | | |
Collapse
|
45
|
Khodyakov D, Williams P, Bromley E, Chung B, Wells K. Using Stakeholder Input to Inform an Innovative Research and Policy Initiative to Improve Depression in Safety Net Communities. Prog Community Health Partnersh 2017; 11:93-98. [PMID: 28529465 DOI: 10.1353/cpr.2017.0012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
THE PROBLEM Depression quality improvement programs based on chronic disease management models have been shown to improve depression outcomes. Nonetheless, access to and the use of such programs is limited in minority, under-resourced communities. PURPOSE OF ARTICLE We report on the outcomes of a Delphi-based consensus exercise conducted by our partnership at a community-wide conference in Los Angeles. Participants identified and prioritized the needs of depressed individuals that should be addressed in a county-wide Health Neighborhood Initiative designed to increase existing mental health, substance use, healthcare, and social services for individuals with low socioeconomic position. KEY POINTS Participants agreed that housing is the number one priority. Delphi results also illustrate the importance of addressing social, spiritual, and healthcare access needs of depressed individuals. CONCLUSIONS Our study shows how to systematically engage community-based organizations, patients, families, and community members in the process of improving the design of community-wide health policy initiatives.
Collapse
Affiliation(s)
| | - Pluscedia Williams
- Healthy African American Families II.,Charles R. Drew University of Medicine and Science
| | - Elizabeth Bromley
- Center for Health Services and Society, Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Bio-behavioral Sciences, David Geffen School of Medicine at University of California Los Angeles.,VA Mental Illness Research, Education and Clinical Center, Greater Los Angeles VA Healthcare System
| | - Bowen Chung
- Center for Health Services and Society, Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Bio-behavioral Sciences, David Geffen School of Medicine at University of California Los Angeles.,Department of Psychiatry, Harbor-UCLA Medical Center/Los Angeles Biomedical Research Institute
| | - Kenneth Wells
- RAND Corporation.,Center for Health Services and Society, Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Bio-behavioral Sciences, David Geffen School of Medicine at University of California Los Angeles.,Department of Health Policy and Management, University of California Los Angeles Fielding School of Public Health
| |
Collapse
|
46
|
Schneider EC, Sorbero ME, Haas A, Ridgely MS, Khodyakov D, Setodji CM, Parry G, Huang SS, Yokoe DS, Goldmann D. Erratum to: Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS. Implement Sci 2017; 12:59. [PMID: 28490372 PMCID: PMC5424490 DOI: 10.1186/s13012-017-0591-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Accepted: 05/04/2017] [Indexed: 11/10/2022] Open
Affiliation(s)
- Eric C Schneider
- RAND Corporation, Santa Monica, CA, USA. .,Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA. .,Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA. .,The Commonwealth Fund, One East 75th Street, New York, NY, 10021, USA.
| | | | - Ann Haas
- RAND Corporation, Santa Monica, CA, USA
| | | | | | | | - Gareth Parry
- Institute for Healthcare Improvement and Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA
| | - Susan S Huang
- Division of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA, USA
| | - Deborah S Yokoe
- Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
| | - Don Goldmann
- Institute for Healthcare Improvement and Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA
| |
Collapse
|
47
|
Khodyakov D, Grant S, Meeker D, Booth M, Pacheco-Santivanez N, Kim KK. Comparative analysis of stakeholder experiences with an online approach to prioritizing patient-centered research topics. J Am Med Inform Assoc 2017; 24:537-543. [PMID: 28011596 PMCID: PMC7651951 DOI: 10.1093/jamia/ocw157] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVE Little evidence exists about effective and scalable methods for meaningful stakeholder engagement in research. We explored patient/caregiver experiences with a high-tech online engagement approach for patient-centered research prioritization, compared their experiences with those of professional stakeholders, and identified factors associated with favorable participant experiences. METHODS We conducted 8 online modified-Delphi (OMD) panels. Panelists participated in 2 rating rounds with a statistical feedback/online discussion round in between. Panels focused on weight management/obesity, heart failure, and Kawasaki disease. We recruited a convenience sample of adults with any of the 3 conditions (or parents/guardians of Kawasaki disease patients), clinicians, and researchers. Measures included self-reported willingness to use OMD again, the panelists' study participation and online discussion experiences, the system's perceived ease of use, and active engagement metrics. RESULTS Out of 349 panelists, 292 (84%) completed the study. Of those, 46% were patients, 36% were clinicians, and 19% were researchers. In multivariate models, patients were not significantly more actively engaged (Odds ratio (OR) = 1.69, 95% confidence interval (CI), 0.94-3.05) but had more favorable study participation (β = 0.49; P ≤ .05) and online discussion (β = 0.18; P ≤ .05) experiences and were more willing to use OMD again (β = 0.36; P ≤ .05), compared to professional stakeholders. Positive perceptions of the OMD system's ease of use (β = 0.16; P ≤ .05) and favorable study participation (β = 0.26; P ≤ .05) and online discussion (β = 0.57; P ≤ .05) experiences were also associated with increased willingness to use OMD in the future. Active engagement was not associated with online experience indices or willingness to use OMD again. CONCLUSION Online approaches to engaging large numbers of stakeholders are a promising and efficient adjunct to in-person meetings.
Collapse
Affiliation(s)
- Dmitry Khodyakov
- RAND Corporation, Santa Monica, CA, USA,Corresponding Author: Dmitry Khodyakov, RAND Corporation, 1776 Main St, PO Box 2138, Santa Monica, CA 90407-2138, USA. E-mail: ; Tel: 310-393-0411, ext. 6159
| | | | - Daniella Meeker
- RAND Corporation, Santa Monica, CA, USA,University of Southern California, Los Angeles, CA, USA
| | | | | | | |
Collapse
|
48
|
Khodyakov D, Kinnett K, Grant S, Lucas A, Martin A, Denger B, Peay H, Coulter I, Fink A. Engaging Patients and Caregivers Managing Rare Diseases to Improve the Methods of Clinical Guideline Development: A Research Protocol. JMIR Res Protoc 2017; 6:e57. [PMID: 28455279 PMCID: PMC5429434 DOI: 10.2196/resprot.6902] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2016] [Accepted: 02/16/2017] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Clinical guidelines provide systematically developed recommendations for deciding on appropriate health care options for specific conditions and clinical circumstances. Up until recently, patients and caregivers have rarely been included in the process of developing care guidelines. OBJECTIVE This project will develop and test a new online method for including patients and their caregivers in this process using Duchenne muscular dystrophy (DMD) care guidelines as an example. The new method will mirror and complement the RAND/UCLA Appropriateness Method (RAM)-the gold standard approach for conducting clinical expert panels that uses a modified Delphi format. RAM is often used in clinical guideline development to determine care appropriateness and necessity in situations where existing clinical evidence is uncertain, weak, or unavailable. METHODS To develop the new method for engaging patients and their caregivers in guideline development, we will first conduct interviews with experts on RAM, guideline development, patient engagement, and patient-centeredness and engage with Duchenne patients and caregivers to identify how RAM should be modified for the purposes of patient engagement and what rating criteria should patients and caregivers use to provide their input during the process of guideline development. Once the new method is piloted, we will test it by conducting two concurrently run patient/caregiver panels that will rate patient-centeredness of a subset of DMD care management recommendations already deemed clinically appropriate and necessary. The ExpertLens™ system-a previously evaluated online modified Delphi system that combines two rounds of rating with a round of feedback and moderated online discussions-will be used to conduct these panels. In addition to developing and testing the new engagement method, we will work with the members of our project's Advisory Board to generate a list of best practices for enhancing the level of patient and caregiver involvement in the guideline development process. We will solicit input on these best practice from Duchenne patients, caregivers, and clinicians by conducting a series of round-table discussions and making a presentation at an annual conference on Duchenne. RESULTS The study protocol was reviewed by RAND's Human Subjects Protection Committee, which determined it to be exempt from review. Interviews with RAM experts have been completed. The projected study completion date is May 2020. CONCLUSIONS We expect that the new method will make it easier to engage large numbers of patients and caregivers in the process of guideline development in a rigorous and culturally appropriate manner that is consistent with the way clinicians participate in guideline development. Moreover, this project will develop best practices that could help involve patients and caregivers in the clinical guideline development process in other clinical areas, thereby facilitating the work of guideline developers.
Collapse
Affiliation(s)
| | - Kathi Kinnett
- Parent Project Muscular Dystrophy, Hackensack, NJ, United States
| | - Sean Grant
- RAND Health, Santa Monica, CA, United States
| | - Ann Lucas
- Parent Project Muscular Dystrophy, Hackensack, NJ, United States
| | - Ann Martin
- Parent Project Muscular Dystrophy, Hackensack, NJ, United States
| | - Brian Denger
- Parent Project Muscular Dystrophy, Hackensack, NJ, United States
| | - Holly Peay
- RTI International, Research Triangle Park, NC, United States
| | | | - Arlene Fink
- University of California Los Angeles, Los Angeles, CA, United States
| |
Collapse
|
49
|
Schneider EC, Sorbero ME, Haas A, Ridgely MS, Khodyakov D, Setodji CM, Parry G, Huang SS, Yokoe DS, Goldmann D. Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS. Implement Sci 2017; 12:51. [PMID: 28412954 PMCID: PMC5393011 DOI: 10.1186/s13012-017-0579-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Accepted: 03/28/2017] [Indexed: 11/25/2022] Open
Abstract
Background A decade ago, the Institute for Healthcare Improvement pioneered a quality improvement (QI) campaign, leveraging organizational and personal social networks to disseminate new practices. There have been few rigorous studies of the QI campaign approach. Methods Project JOINTS (Joining Organizations IN Tackling SSIs) engaged a network of state-based organizations and professionals in a 6-month QI campaign promoting adherence to three new evidence-based practices known to reduce the risk of infection after joint replacement. We conducted a cluster-randomized trial including ten states (five campaign states and five non-campaign states) with 188 hospitals providing joint replacement to Medicare. We measured adherence to the evidence-based practices before and after the campaign using a survey of surgical staff and a difference-in-difference design with multivariable adjustment to compare adherence to each of the relevant practices and an all-or-none composite measure of the three new practices. Results In the campaign states, there were statistically significant increases in adherence to the three new evidence-based practices promoted by the campaign. Compared to the non-campaign states, the relative increase in adherence to the three new practices in the campaign states ranged between 1.9 and 15.9 percentage points, but only one of these changes (pre-operative nasal screening for Staphylococcus aureus carriage and decolonization prior to surgery) was statistically significant (p < 0.05). On the all-or-none composite measure, adherence to all three evidence-based practices increased from 19.6 to 37.9% in the campaign states, but declined slightly in the comparison states, yielding a relative increase of 23 percentage points (p = 0.004). In the non-campaign states, changes in adherence were not statistically significant. Conclusions Within 6 months, in a cluster-randomized trial, a multi-state campaign targeting hospitals and professionals involved in surgical care and infection control was associated with an increase in adherence to evidence-based practices that can reduce surgical site infection. Electronic supplementary material The online version of this article (doi:10.1186/s13012-017-0579-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Eric C Schneider
- RAND Corporation, Santa Monica, CA, USA. .,Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA. .,Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA. .,The Commonwealth Fund, One East 75th Street, New York, NY, 10021, USA.
| | | | - Ann Haas
- RAND Corporation, Santa Monica, CA, USA
| | | | | | | | - Gareth Parry
- Institute for Healthcare Improvement and Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA
| | - Susan S Huang
- Division of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA, USA
| | - Deborah S Yokoe
- Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
| | - Don Goldmann
- Institute for Healthcare Improvement and Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA
| |
Collapse
|
50
|
Khodyakov D, Grant S, Barber CEH, Marshall DA, Esdaile JM, Lacaille D. Acceptability of an online modified Delphi panel approach for developing health services performance measures: results from 3 panels on arthritis research. J Eval Clin Pract 2017; 23:354-360. [PMID: 27619536 DOI: 10.1111/jep.12623] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2016] [Revised: 07/11/2016] [Accepted: 07/12/2016] [Indexed: 01/23/2023]
Abstract
RATIONALE, AIMS, AND OBJECTIVES Online modified Delphi (OMD) panel approaches can be used to engage large and diverse groups of clinical experts and stakeholders in developing health services performance measures. Such approaches are increasing in popularity among health researchers. However, information about their acceptability to participating experts and stakeholders is lacking but important to determine before recommending widespread use of online approaches. Therefore, the objective of this paper is to explore acceptability of the OMD panel approach from the participants' perspective. METHOD We use data from participants in three OMD panels designed to develop performance measures for use in arthritis research and quality improvement efforts. At the end of each online panel, we surveyed clinical experts and stakeholders who shared their experiences with the OMD process by answering 13 close-ended questions using 7-point Likert-type scales. A mean of 5 or higher on a given question was treated as an indication of acceptability. RESULTS Ninety-eight clinical experts and stakeholders (92% participation rate) answered survey questions about the online process. They considered the OMD panel approach to be acceptable, particularly the ease of using the online system (mean = 5.3, standard deviation = 1.3) and the understanding gained from online discussions (mean = 5.2, standard deviation = 1.0). Participants also felt that participation in the Delphi study was interesting (mean = 5.6, standard deviation =1.1). CONCLUSION These findings illustrate likely acceptability and a potential for a more widespread use of OMD panel approaches by stakeholders in developing health services performance measures.
Collapse
Affiliation(s)
| | | | - Claire E H Barber
- University of Calgary; Arthritis Research Centre Canada, Calgary, Canada
| | - Deborah A Marshall
- University of Calgary; Arthritis Research Centre Canada, Calgary, Canada
| | | | | |
Collapse
|